#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Comparison of large-scale human brain functional and anatomical networks in schizophrenia Schizophrenia is a disease with disruptions in thought, emotion, and behavior.
1-1	0-10	Comparison	_
1-2	11-13	of	_
1-3	14-25	large-scale	_
1-4	26-31	human	_
1-5	32-37	brain	_
1-6	38-48	functional	_
1-7	49-52	and	_
1-8	53-63	anatomical	_
1-9	64-72	networks	_
1-10	73-75	in	_
1-11	76-89	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-12	90-103	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-13	104-106	is	_
1-14	107-108	a	_
1-15	109-116	disease	_
1-16	117-121	with	_
1-17	122-133	disruptions	_
1-18	134-136	in	_
1-19	137-144	thought	_
1-20	145-146	,	_
1-21	147-154	emotion	_
1-22	155-156	,	_
1-23	157-160	and	_
1-24	161-169	behavior	_
1-25	170-171	.	_

Text=The dysconnectivity hypothesis suggests these disruptions are due to aberrant brain connectivity.
2-1	172-175	The	_
2-2	176-191	dysconnectivity	_
2-3	192-202	hypothesis	_
2-4	203-211	suggests	_
2-5	212-217	these	_
2-6	218-229	disruptions	_
2-7	230-233	are	_
2-8	234-237	due	_
2-9	238-240	to	_
2-10	241-249	aberrant	_
2-11	250-255	brain	_
2-12	256-268	connectivity	_
2-13	269-270	.	_

Text=Many studies have identified connectivity differences but few have been able to unify gray and white matter findings into one model.
3-1	271-275	Many	_
3-2	276-283	studies	_
3-3	284-288	have	_
3-4	289-299	identified	_
3-5	300-312	connectivity	_
3-6	313-324	differences	_
3-7	325-328	but	_
3-8	329-332	few	_
3-9	333-337	have	_
3-10	338-342	been	_
3-11	343-347	able	_
3-12	348-350	to	_
3-13	351-356	unify	_
3-14	357-361	gray	_
3-15	362-365	and	_
3-16	366-371	white	_
3-17	372-378	matter	_
3-18	379-387	findings	_
3-19	388-392	into	_
3-20	393-396	one	_
3-21	397-402	model	_
3-22	403-404	.	_

Text=Here we develop an extension of the Network-Based Statistic (NBS) called NBSm (Multimodal Network-based statistic) to compare functional and anatomical networks in schizophrenia.
4-1	405-409	Here	_
4-2	410-412	we	_
4-3	413-420	develop	_
4-4	421-423	an	_
4-5	424-433	extension	_
4-6	434-436	of	_
4-7	437-440	the	_
4-8	441-454	Network-Based	_
4-9	455-464	Statistic	_
4-10	465-466	(	_
4-11	467-470	NBS	_
4-12	471-472	)	_
4-13	473-479	called	_
4-14	480-484	NBSm	_
4-15	485-486	(	_
4-16	487-497	Multimodal	_
4-17	498-511	Network-based	_
4-18	512-521	statistic	_
4-19	522-523	)	_
4-20	524-526	to	_
4-21	527-534	compare	_
4-22	535-545	functional	_
4-23	546-549	and	_
4-24	550-560	anatomical	_
4-25	561-569	networks	_
4-26	570-572	in	_
4-27	573-586	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-28	587-588	.	_

Text=Structural, resting functional, and diffusion magnetic resonance imaging data were collected from 29 chronic patients with schizophrenia and 29 healthy controls.
5-1	589-599	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
5-2	600-601	,	_
5-3	602-609	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-4	610-620	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-5	621-622	,	_
5-6	623-626	and	_
5-7	627-636	diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
5-8	637-645	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
5-9	646-655	resonance	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
5-10	656-663	imaging	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
5-11	664-668	data	_
5-12	669-673	were	_
5-13	674-683	collected	_
5-14	684-688	from	_
5-15	689-691	29	_
5-16	692-699	chronic	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-17	700-708	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-18	709-713	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-19	714-727	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-20	728-731	and	_
5-21	732-734	29	_
5-22	735-742	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-23	743-751	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-24	752-753	.	_

Text=Images were preprocessed, and average time courses were extracted for 90 regions of interest (ROI).
6-1	754-760	Images	_
6-2	761-765	were	_
6-3	766-778	preprocessed	_
6-4	779-780	,	_
6-5	781-784	and	_
6-6	785-792	average	_
6-7	793-797	time	_
6-8	798-805	courses	_
6-9	806-810	were	_
6-10	811-820	extracted	_
6-11	821-824	for	_
6-12	825-827	90	_
6-13	828-835	regions	_
6-14	836-838	of	_
6-15	839-847	interest	_
6-16	848-849	(	_
6-17	850-853	ROI	_
6-18	854-855	)	_
6-19	856-857	.	_

Text=Functional connectivity matrices were estimated by pairwise correlations between wavelet coefficients of ROI time series.
7-1	858-868	Functional	_
7-2	869-881	connectivity	_
7-3	882-890	matrices	_
7-4	891-895	were	_
7-5	896-905	estimated	_
7-6	906-908	by	_
7-7	909-917	pairwise	_
7-8	918-930	correlations	_
7-9	931-938	between	_
7-10	939-946	wavelet	_
7-11	947-959	coefficients	_
7-12	960-962	of	_
7-13	963-966	ROI	_
7-14	967-971	time	_
7-15	972-978	series	_
7-16	979-980	.	_

Text=Following diffusion tractography, anatomical connectivity matrices were estimated by white matter streamline counts between each pair of ROIs.
8-1	981-990	Following	_
8-2	991-1000	diffusion	_
8-3	1001-1013	tractography	_
8-4	1014-1015	,	_
8-5	1016-1026	anatomical	_
8-6	1027-1039	connectivity	_
8-7	1040-1048	matrices	_
8-8	1049-1053	were	_
8-9	1054-1063	estimated	_
8-10	1064-1066	by	_
8-11	1067-1072	white	_
8-12	1073-1079	matter	_
8-13	1080-1090	streamline	_
8-14	1091-1097	counts	_
8-15	1098-1105	between	_
8-16	1106-1110	each	_
8-17	1111-1115	pair	_
8-18	1116-1118	of	_
8-19	1119-1123	ROIs	_
8-20	1124-1125	.	_

Text=Global and regional strength were calculated for each modality.
9-1	1126-1132	Global	_
9-2	1133-1136	and	_
9-3	1137-1145	regional	_
9-4	1146-1154	strength	_
9-5	1155-1159	were	_
9-6	1160-1170	calculated	_
9-7	1171-1174	for	_
9-8	1175-1179	each	_
9-9	1180-1188	modality	_
9-10	1189-1190	.	_

Text=NBSm was used to find significant overlap between functional and anatomical components that distinguished health from schizophrenia.
10-1	1191-1195	NBSm	_
10-2	1196-1199	was	_
10-3	1200-1204	used	_
10-4	1205-1207	to	_
10-5	1208-1212	find	_
10-6	1213-1224	significant	_
10-7	1225-1232	overlap	_
10-8	1233-1240	between	_
10-9	1241-1251	functional	_
10-10	1252-1255	and	_
10-11	1256-1266	anatomical	_
10-12	1267-1277	components	_
10-13	1278-1282	that	_
10-14	1283-1296	distinguished	_
10-15	1297-1303	health	_
10-16	1304-1308	from	_
10-17	1309-1322	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-18	1323-1324	.	_

Text=Global strength was decreased in patients in both functional and anatomical networks.
11-1	1325-1331	Global	_
11-2	1332-1340	strength	_
11-3	1341-1344	was	_
11-4	1345-1354	decreased	_
11-5	1355-1357	in	_
11-6	1358-1366	patients	_
11-7	1367-1369	in	_
11-8	1370-1374	both	_
11-9	1375-1385	functional	_
11-10	1386-1389	and	_
11-11	1390-1400	anatomical	_
11-12	1401-1409	networks	_
11-13	1410-1411	.	_

Text=Regional strength was decreased in all regions in functional networks and only one region in anatomical networks.
12-1	1412-1420	Regional	_
12-2	1421-1429	strength	_
12-3	1430-1433	was	_
12-4	1434-1443	decreased	_
12-5	1444-1446	in	_
12-6	1447-1450	all	_
12-7	1451-1458	regions	_
12-8	1459-1461	in	_
12-9	1462-1472	functional	_
12-10	1473-1481	networks	_
12-11	1482-1485	and	_
12-12	1486-1490	only	_
12-13	1491-1494	one	_
12-14	1495-1501	region	_
12-15	1502-1504	in	_
12-16	1505-1515	anatomical	_
12-17	1516-1524	networks	_
12-18	1525-1526	.	_

Text=NBSm identified a distinguishing functional component consisting of 46 nodes with 113 links (p <0.001), a distinguishing anatomical component with 47 nodes and 50 links (p = 0.002), and a distinguishing intermodal component with 26 nodes (p <0.001).
13-1	1527-1531	NBSm	_
13-2	1532-1542	identified	_
13-3	1543-1544	a	_
13-4	1545-1559	distinguishing	_
13-5	1560-1570	functional	_
13-6	1571-1580	component	_
13-7	1581-1591	consisting	_
13-8	1592-1594	of	_
13-9	1595-1597	46	_
13-10	1598-1603	nodes	_
13-11	1604-1608	with	_
13-12	1609-1612	113	_
13-13	1613-1618	links	_
13-14	1619-1620	(	_
13-15	1621-1622	p	_
13-16	1623-1624	<	_
13-17	1625-1630	0.001	_
13-18	1631-1632	)	_
13-19	1633-1634	,	_
13-20	1635-1636	a	_
13-21	1637-1651	distinguishing	_
13-22	1652-1662	anatomical	_
13-23	1663-1672	component	_
13-24	1673-1677	with	_
13-25	1678-1680	47	_
13-26	1681-1686	nodes	_
13-27	1687-1690	and	_
13-28	1691-1693	50	_
13-29	1694-1699	links	_
13-30	1700-1701	(	_
13-31	1702-1703	p	_
13-32	1704-1705	=	_
13-33	1706-1711	0.002	_
13-34	1712-1713	)	_
13-35	1714-1715	,	_
13-36	1716-1719	and	_
13-37	1720-1721	a	_
13-38	1722-1736	distinguishing	_
13-39	1737-1747	intermodal	_
13-40	1748-1757	component	_
13-41	1758-1762	with	_
13-42	1763-1765	26	_
13-43	1766-1771	nodes	_
13-44	1772-1773	(	_
13-45	1774-1775	p	_
13-46	1776-1777	<	_
13-47	1778-1783	0.001	_
13-48	1784-1785	)	_
13-49	1786-1787	.	_

Text=NBSm is a powerful technique for understanding network-based group differences present in both anatomical and functional data.
14-1	1788-1792	NBSm	_
14-2	1793-1795	is	_
14-3	1796-1797	a	_
14-4	1798-1806	powerful	_
14-5	1807-1816	technique	_
14-6	1817-1820	for	_
14-7	1821-1834	understanding	_
14-8	1835-1848	network-based	_
14-9	1849-1854	group	_
14-10	1855-1866	differences	_
14-11	1867-1874	present	_
14-12	1875-1877	in	_
14-13	1878-1882	both	_
14-14	1883-1893	anatomical	_
14-15	1894-1897	and	_
14-16	1898-1908	functional	_
14-17	1909-1913	data	_
14-18	1914-1915	.	_

Text=In light of the dysconnectivity hypothesis, these results provide compelling evidence for the presence of significant overlapping anatomical and functional disruption in people with schizophrenia.
15-1	1916-1918	In	_
15-2	1919-1924	light	_
15-3	1925-1927	of	_
15-4	1928-1931	the	_
15-5	1932-1947	dysconnectivity	_
15-6	1948-1958	hypothesis	_
15-7	1959-1960	,	_
15-8	1961-1966	these	_
15-9	1967-1974	results	_
15-10	1975-1982	provide	_
15-11	1983-1993	compelling	_
15-12	1994-2002	evidence	_
15-13	2003-2006	for	_
15-14	2007-2010	the	_
15-15	2011-2019	presence	_
15-16	2020-2022	of	_
15-17	2023-2034	significant	_
15-18	2035-2046	overlapping	_
15-19	2047-2057	anatomical	_
15-20	2058-2061	and	_
15-21	2062-2072	functional	_
15-22	2073-2083	disruption	_
15-23	2084-2086	in	_
15-24	2087-2093	people	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-25	2094-2098	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-26	2099-2112	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-27	2113-2114	.	_

Text=Highlights A novel method for the unified analysis of functional and anatomical networks in schizophrenia is proposed.
16-1	2115-2125	Highlights	_
16-2	2126-2127	A	_
16-3	2128-2133	novel	_
16-4	2134-2140	method	_
16-5	2141-2144	for	_
16-6	2145-2148	the	_
16-7	2149-2156	unified	_
16-8	2157-2165	analysis	_
16-9	2166-2168	of	_
16-10	2169-2179	functional	_
16-11	2180-2183	and	_
16-12	2184-2194	anatomical	_
16-13	2195-2203	networks	_
16-14	2204-2206	in	_
16-15	2207-2220	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
16-16	2221-2223	is	_
16-17	2224-2232	proposed	_
16-18	2233-2234	.	_

Text=The methodology extends existing networkbased analyses to test brain network differences across imaging modalities.
17-1	2235-2238	The	_
17-2	2239-2250	methodology	_
17-3	2251-2258	extends	_
17-4	2259-2267	existing	_
17-5	2268-2280	networkbased	_
17-6	2281-2289	analyses	_
17-7	2290-2292	to	_
17-8	2293-2297	test	_
17-9	2298-2303	brain	_
17-10	2304-2311	network	_
17-11	2312-2323	differences	_
17-12	2324-2330	across	_
17-13	2331-2338	imaging	_
17-14	2339-2349	modalities	_
17-15	2350-2351	.	_

Text=A fundamental disrupted network was found in those with schizophrenia when compared to healthy, agematched controls.
18-1	2352-2353	A	_
18-2	2354-2365	fundamental	_
18-3	2366-2375	disrupted	_
18-4	2376-2383	network	_
18-5	2384-2387	was	_
18-6	2388-2393	found	_
18-7	2394-2396	in	_
18-8	2397-2402	those	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-9	2403-2407	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-10	2408-2421	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-11	2422-2426	when	_
18-12	2427-2435	compared	_
18-13	2436-2438	to	_
18-14	2439-2446	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-15	2447-2448	,	_
18-16	2449-2459	agematched	_
18-17	2460-2468	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-18	2469-2470	.	_

Text=Methods and materials Participants Data from 29 participants with chronic schizophrenia (11 females; age 41.3 ± 9.3 (SD); 5 left-handed) and 29 healthy participants (11 females; age 41.1 ± 10.6 (SD); 2 left-handed) were included in this analysis.
19-1	2471-2478	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
19-2	2479-2482	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
19-3	2483-2492	materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
19-4	2493-2505	Participants	_
19-5	2506-2510	Data	_
19-6	2511-2515	from	_
19-7	2516-2518	29	_
19-8	2519-2531	participants	http://maven.renci.org/NeuroBridge/neurobridge#ChronicCatatonicSchizophreniawithAcuteExacerbation
19-9	2532-2536	with	http://maven.renci.org/NeuroBridge/neurobridge#ChronicCatatonicSchizophreniawithAcuteExacerbation
19-10	2537-2544	chronic	http://maven.renci.org/NeuroBridge/neurobridge#ChronicCatatonicSchizophreniawithAcuteExacerbation
19-11	2545-2558	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#ChronicCatatonicSchizophreniawithAcuteExacerbation
19-12	2559-2560	(	_
19-13	2561-2563	11	_
19-14	2564-2571	females	_
19-15	2572-2573	;	_
19-16	2574-2577	age	_
19-17	2578-2582	41.3	_
19-18	2583-2584	±	_
19-19	2585-2588	9.3	_
19-20	2589-2590	(	_
19-21	2591-2593	SD	_
19-22	2594-2595	)	_
19-23	2596-2597	;	_
19-24	2598-2599	5	_
19-25	2600-2611	left-handed	_
19-26	2612-2613	)	_
19-27	2614-2617	and	_
19-28	2618-2620	29	_
19-29	2621-2628	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-30	2629-2641	participants	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-31	2642-2643	(	_
19-32	2644-2646	11	_
19-33	2647-2654	females	_
19-34	2655-2656	;	_
19-35	2657-2660	age	_
19-36	2661-2665	41.1	_
19-37	2666-2667	±	_
19-38	2668-2672	10.6	_
19-39	2673-2674	(	_
19-40	2675-2677	SD	_
19-41	2678-2679	)	_
19-42	2680-2681	;	_
19-43	2682-2683	2	_
19-44	2684-2695	left-handed	_
19-45	2696-2697	)	_
19-46	2698-2702	were	_
19-47	2703-2711	included	_
19-48	2712-2714	in	_
19-49	2715-2719	this	_
19-50	2720-2728	analysis	_
19-51	2729-2730	.	_

Text=All participants provided written informed consent and received payment for the time they spent participating.
20-1	2731-2734	All	_
20-2	2735-2747	participants	_
20-3	2748-2756	provided	_
20-4	2757-2764	written	_
20-5	2765-2773	informed	_
20-6	2774-2781	consent	_
20-7	2782-2785	and	_
20-8	2786-2794	received	_
20-9	2795-2802	payment	_
20-10	2803-2806	for	_
20-11	2807-2810	the	_
20-12	2811-2815	time	_
20-13	2816-2820	they	_
20-14	2821-2826	spent	_
20-15	2827-2840	participating	_
20-16	2841-2842	.	_

Text=The consent process and all procedures were reviewed and approved by the institutional review board (IRB) at the University of Minnesota prior to initiating studies.
21-1	2843-2846	The	_
21-2	2847-2854	consent	_
21-3	2855-2862	process	_
21-4	2863-2866	and	_
21-5	2867-2870	all	_
21-6	2871-2881	procedures	_
21-7	2882-2886	were	_
21-8	2887-2895	reviewed	_
21-9	2896-2899	and	_
21-10	2900-2908	approved	_
21-11	2909-2911	by	_
21-12	2912-2915	the	_
21-13	2916-2929	institutional	_
21-14	2930-2936	review	_
21-15	2937-2942	board	_
21-16	2943-2944	(	_
21-17	2945-2948	IRB	_
21-18	2949-2950	)	_
21-19	2951-2953	at	_
21-20	2954-2957	the	_
21-21	2958-2968	University	_
21-22	2969-2971	of	_
21-23	2972-2981	Minnesota	_
21-24	2982-2987	prior	_
21-25	2988-2990	to	_
21-26	2991-3001	initiating	_
21-27	3002-3009	studies	_
21-28	3010-3011	.	_

Text=Schizophrenia patients were diagnosed with the Structured Clinical Interview for DSM-IV.
22-1	3012-3025	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
22-2	3026-3034	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
22-3	3035-3039	were	_
22-4	3040-3049	diagnosed	_
22-5	3050-3054	with	_
22-6	3055-3058	the	_
22-7	3059-3069	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
22-8	3070-3078	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
22-9	3079-3088	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
22-10	3089-3092	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
22-11	3093-3099	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
22-12	3100-3101	.	_

Text=Out of the 29 chronic schizophrenia patients: 16 were taking 1 atypical antipsychotic, 8 were taking 2 atypical antipsychotics, 1 was taking 1 typical antipsychotic, 1 was taking 1 atypical and 1 typical antipsychotic, 1 was taking 2 atypical and 1 atypical antipsychotics, and 2 were not taking any antipsychotic.
23-1	3102-3105	Out	_
23-2	3106-3108	of	_
23-3	3109-3112	the	_
23-4	3113-3115	29	_
23-5	3116-3123	chronic	http://maven.renci.org/NeuroBridge/neurobridge#ChronicSchizophrenia
23-6	3124-3137	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#ChronicSchizophrenia
23-7	3138-3146	patients	_
23-8	3147-3148	:	_
23-9	3149-3151	16	_
23-10	3152-3156	were	_
23-11	3157-3163	taking	_
23-12	3164-3165	1	_
23-13	3166-3174	atypical	_
23-14	3175-3188	antipsychotic	_
23-15	3189-3190	,	_
23-16	3191-3192	8	_
23-17	3193-3197	were	_
23-18	3198-3204	taking	_
23-19	3205-3206	2	_
23-20	3207-3215	atypical	_
23-21	3216-3230	antipsychotics	_
23-22	3231-3232	,	_
23-23	3233-3234	1	_
23-24	3235-3238	was	_
23-25	3239-3245	taking	_
23-26	3246-3247	1	_
23-27	3248-3255	typical	_
23-28	3256-3269	antipsychotic	_
23-29	3270-3271	,	_
23-30	3272-3273	1	_
23-31	3274-3277	was	_
23-32	3278-3284	taking	_
23-33	3285-3286	1	_
23-34	3287-3295	atypical	_
23-35	3296-3299	and	_
23-36	3300-3301	1	_
23-37	3302-3309	typical	_
23-38	3310-3323	antipsychotic	_
23-39	3324-3325	,	_
23-40	3326-3327	1	_
23-41	3328-3331	was	_
23-42	3332-3338	taking	_
23-43	3339-3340	2	_
23-44	3341-3349	atypical	_
23-45	3350-3353	and	_
23-46	3354-3355	1	_
23-47	3356-3364	atypical	_
23-48	3365-3379	antipsychotics	_
23-49	3380-3381	,	_
23-50	3382-3385	and	_
23-51	3386-3387	2	_
23-52	3388-3392	were	_
23-53	3393-3396	not	_
23-54	3397-3403	taking	_
23-55	3404-3407	any	_
23-56	3408-3421	antipsychotic	_
23-57	3422-3423	.	_

Text=Participants were excluded if they fulfilled the criteria for Alcohol or Substance Abuse or Dependence described in the Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition within 3 months prior to scanning, significant medical illness, or head injury resulting in loss of consciousness exceeding 30 min.
24-1	3424-3436	Participants	_
24-2	3437-3441	were	_
24-3	3442-3450	excluded	_
24-4	3451-3453	if	_
24-5	3454-3458	they	_
24-6	3459-3468	fulfilled	_
24-7	3469-3472	the	_
24-8	3473-3481	criteria	_
24-9	3482-3485	for	_
24-10	3486-3493	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
24-11	3494-3496	or	_
24-12	3497-3506	Substance	_
24-13	3507-3512	Abuse	_
24-14	3513-3515	or	_
24-15	3516-3526	Dependence	_
24-16	3527-3536	described	_
24-17	3537-3539	in	_
24-18	3540-3543	the	_
24-19	3544-3554	Diagnostic	_
24-20	3555-3558	and	_
24-21	3559-3570	Statistical	_
24-22	3571-3577	Manual	_
24-23	3578-3580	of	_
24-24	3581-3587	Mental	_
24-25	3588-3596	Disorder	_
24-26	3597-3598	,	_
24-27	3599-3605	Fourth	_
24-28	3606-3613	Edition	_
24-29	3614-3620	within	_
24-30	3621-3622	3	_
24-31	3623-3629	months	_
24-32	3630-3635	prior	_
24-33	3636-3638	to	_
24-34	3639-3647	scanning	_
24-35	3648-3649	,	_
24-36	3650-3661	significant	_
24-37	3662-3669	medical	_
24-38	3670-3677	illness	_
24-39	3678-3679	,	_
24-40	3680-3682	or	_
24-41	3683-3687	head	_
24-42	3688-3694	injury	_
24-43	3695-3704	resulting	_
24-44	3705-3707	in	_
24-45	3708-3712	loss	_
24-46	3713-3715	of	_
24-47	3716-3729	consciousness	_
24-48	3730-3739	exceeding	_
24-49	3740-3742	30	_
24-50	3743-3746	min	_
24-51	3747-3748	.	_

Text=Education and occupational status were determined with the Socioeconomic Status questionnaire.
25-1	3749-3758	Education	_
25-2	3759-3762	and	_
25-3	3763-3775	occupational	_
25-4	3776-3782	status	_
25-5	3783-3787	were	_
25-6	3788-3798	determined	_
25-7	3799-3803	with	_
25-8	3804-3807	the	_
25-9	3808-3821	Socioeconomic	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus
25-10	3822-3828	Status	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus
25-11	3829-3842	questionnaire	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus
25-12	3843-3844	.	_

Text=See for a detailed breakdown of educational and socioeconomic status.
26-1	3845-3848	See	_
26-2	3849-3852	for	_
26-3	3853-3854	a	_
26-4	3855-3863	detailed	_
26-5	3864-3873	breakdown	_
26-6	3874-3876	of	_
26-7	3877-3888	educational	_
26-8	3889-3892	and	_
26-9	3893-3906	socioeconomic	_
26-10	3907-3913	status	_
26-11	3914-3915	.	_

Text=Groups were matched by levels of education (t (55) = 0.06, p = 0.952) and occupational status (t (55) = 1.191, p = 0.239) of primary caregivers.
27-1	3916-3922	Groups	_
27-2	3923-3927	were	_
27-3	3928-3935	matched	_
27-4	3936-3938	by	_
27-5	3939-3945	levels	_
27-6	3946-3948	of	_
27-7	3949-3958	education	_
27-8	3959-3960	(	_
27-9	3961-3962	t	_
27-10	3963-3964	(	_
27-11	3965-3967	55	_
27-12	3968-3969	)	_
27-13	3970-3971	=	_
27-14	3972-3976	0.06	_
27-15	3977-3978	,	_
27-16	3979-3980	p	_
27-17	3981-3982	=	_
27-18	3983-3988	0.952	_
27-19	3989-3990	)	_
27-20	3991-3994	and	_
27-21	3995-4007	occupational	_
27-22	4008-4014	status	_
27-23	4015-4016	(	_
27-24	4017-4018	t	_
27-25	4019-4020	(	_
27-26	4021-4023	55	_
27-27	4024-4025	)	_
27-28	4026-4027	=	_
27-29	4028-4033	1.191	_
27-30	4034-4035	,	_
27-31	4036-4037	p	_
27-32	4038-4039	=	_
27-33	4040-4045	0.239	_
27-34	4046-4047	)	_
27-35	4048-4050	of	_
27-36	4051-4058	primary	_
27-37	4059-4069	caregivers	_
27-38	4070-4071	.	_

Text=Healthy participants, however, had significantly higher levels of education (t (55) = 5.01, p <0.001) and occupational status (t (55) = 5.78, p <0.001).
28-1	4072-4079	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
28-2	4080-4092	participants	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
28-3	4093-4094	,	_
28-4	4095-4102	however	_
28-5	4103-4104	,	_
28-6	4105-4108	had	_
28-7	4109-4122	significantly	_
28-8	4123-4129	higher	_
28-9	4130-4136	levels	_
28-10	4137-4139	of	_
28-11	4140-4149	education	_
28-12	4150-4151	(	_
28-13	4152-4153	t	_
28-14	4154-4155	(	_
28-15	4156-4158	55	_
28-16	4159-4160	)	_
28-17	4161-4162	=	_
28-18	4163-4167	5.01	_
28-19	4168-4169	,	_
28-20	4170-4171	p	_
28-21	4172-4173	<	_
28-22	4174-4179	0.001	_
28-23	4180-4181	)	_
28-24	4182-4185	and	_
28-25	4186-4198	occupational	_
28-26	4199-4205	status	_
28-27	4206-4207	(	_
28-28	4208-4209	t	_
28-29	4210-4211	(	_
28-30	4212-4214	55	_
28-31	4215-4216	)	_
28-32	4217-4218	=	_
28-33	4219-4223	5.78	_
28-34	4224-4225	,	_
28-35	4226-4227	p	_
28-36	4228-4229	<	_
28-37	4230-4235	0.001	_
28-38	4236-4237	)	_
28-39	4238-4239	.	_

Text=See for a detailed analysis of the whole-brain resting state connectivity in this population.
29-1	4240-4243	See	_
29-2	4244-4247	for	_
29-3	4248-4249	a	_
29-4	4250-4258	detailed	_
29-5	4259-4267	analysis	_
29-6	4268-4270	of	_
29-7	4271-4274	the	_
29-8	4275-4286	whole-brain	_
29-9	4287-4294	resting	_
29-10	4295-4300	state	_
29-11	4301-4313	connectivity	_
29-12	4314-4316	in	_
29-13	4317-4321	this	_
29-14	4322-4332	population	_
29-15	4333-4334	.	_

Text=Imaging Structural (sMRI), functional (fMRI), and diffusion weighted (DTI) magnetic resonance images were acquired for all participants on a Siemens 3.0 T Trio scanner (Erlangen, Germany).
30-1	4335-4342	Imaging	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
30-2	4343-4353	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
30-3	4354-4355	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
30-4	4356-4360	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
30-5	4361-4362	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
30-6	4363-4364	,	_
30-7	4365-4375	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
30-8	4376-4377	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
30-9	4378-4382	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
30-10	4383-4384	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
30-11	4385-4386	,	_
30-12	4387-4390	and	_
30-13	4391-4400	diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
30-14	4401-4409	weighted	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
30-15	4410-4411	(	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
30-16	4412-4415	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
30-17	4416-4417	)	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
30-18	4418-4426	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
30-19	4427-4436	resonance	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
30-20	4437-4443	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
30-21	4444-4448	were	_
30-22	4449-4457	acquired	_
30-23	4458-4461	for	_
30-24	4462-4465	all	_
30-25	4466-4478	participants	_
30-26	4479-4481	on	_
30-27	4482-4483	a	_
30-28	4484-4491	Siemens	_
30-29	4492-4495	3.0	_
30-30	4496-4497	T	http://maven.renci.org/NeuroBridge/neurobridge#2Level
30-31	4498-4502	Trio	_
30-32	4503-4510	scanner	_
30-33	4511-4512	(	_
30-34	4513-4521	Erlangen	_
30-35	4522-4523	,	_
30-36	4524-4531	Germany	_
30-37	4532-4533	)	_
30-38	4534-4535	.	_

Text=All images were acquired in a single scanning session.
31-1	4536-4539	All	_
31-2	4540-4546	images	_
31-3	4547-4551	were	_
31-4	4552-4560	acquired	_
31-5	4561-4563	in	_
31-6	4564-4565	a	_
31-7	4566-4572	single	_
31-8	4573-4581	scanning	_
31-9	4582-4589	session	_
31-10	4590-4591	.	_

Text=The resting state fMRI scan lasted for approximately 6 min.
32-1	4592-4595	The	_
32-2	4596-4603	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
32-3	4604-4609	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
32-4	4610-4614	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
32-5	4615-4619	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
32-6	4620-4626	lasted	_
32-7	4627-4630	for	_
32-8	4631-4644	approximately	_
32-9	4645-4646	6	_
32-10	4647-4650	min	_
32-11	4651-4652	.	_

Text=Participants were given instructions to remain still, keep their eyes closed, and remain awake.
33-1	4653-4665	Participants	_
33-2	4666-4670	were	_
33-3	4671-4676	given	_
33-4	4677-4689	instructions	_
33-5	4690-4692	to	_
33-6	4693-4699	remain	_
33-7	4700-4705	still	_
33-8	4706-4707	,	_
33-9	4708-4712	keep	_
33-10	4713-4718	their	_
33-11	4719-4723	eyes	_
33-12	4724-4730	closed	_
33-13	4731-4732	,	_
33-14	4733-4736	and	_
33-15	4737-4743	remain	_
33-16	4744-4749	awake	_
33-17	4750-4751	.	_

Text=The scan utilized a gradient-echo echo-planar imaging (EPI) sequence of 180 volumes, a TR (repetition time) of 2 s, TE (echo time) of 30 ms, flip angle of 90° and consisted of 34 continuous AC-PC aligned axial slices with a voxel size of 3.4 × 3.4 × 4.0 mm and an acquisition matrix size of 64 × 64 × 34.
34-1	4752-4755	The	_
34-2	4756-4760	scan	_
34-3	4761-4769	utilized	_
34-4	4770-4771	a	_
34-5	4772-4785	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
34-6	4786-4797	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
34-7	4798-4805	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
34-8	4806-4807	(	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
34-9	4808-4811	EPI	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
34-10	4812-4813	)	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
34-11	4814-4822	sequence	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
34-12	4823-4825	of	_
34-13	4826-4829	180	_
34-14	4830-4837	volumes	_
34-15	4838-4839	,	_
34-16	4840-4841	a	_
34-17	4842-4844	TR	_
34-18	4845-4846	(	_
34-19	4847-4857	repetition	_
34-20	4858-4862	time	_
34-21	4863-4864	)	_
34-22	4865-4867	of	_
34-23	4868-4869	2	_
34-24	4870-4871	s	_
34-25	4872-4873	,	_
34-26	4874-4876	TE	_
34-27	4877-4878	(	_
34-28	4879-4883	echo	_
34-29	4884-4888	time	_
34-30	4889-4890	)	_
34-31	4891-4893	of	_
34-32	4894-4896	30	_
34-33	4897-4899	ms	_
34-34	4900-4901	,	_
34-35	4902-4906	flip	_
34-36	4907-4912	angle	_
34-37	4913-4915	of	_
34-38	4916-4919	90°	_
34-39	4920-4923	and	_
34-40	4924-4933	consisted	_
34-41	4934-4936	of	_
34-42	4937-4939	34	_
34-43	4940-4950	continuous	_
34-44	4951-4956	AC-PC	_
34-45	4957-4964	aligned	_
34-46	4965-4970	axial	_
34-47	4971-4977	slices	_
34-48	4978-4982	with	_
34-49	4983-4984	a	_
34-50	4985-4990	voxel	_
34-51	4991-4995	size	_
34-52	4996-4998	of	_
34-53	4999-5002	3.4	_
34-54	5003-5004	×	_
34-55	5005-5008	3.4	_
34-56	5009-5010	×	_
34-57	5011-5014	4.0	_
34-58	5015-5017	mm	_
34-59	5018-5021	and	_
34-60	5022-5024	an	_
34-61	5025-5036	acquisition	_
34-62	5037-5043	matrix	_
34-63	5044-5048	size	_
34-64	5049-5051	of	_
34-65	5052-5054	64	_
34-66	5055-5056	×	_
34-67	5057-5059	64	_
34-68	5060-5061	×	_
34-69	5062-5064	34	_
34-70	5065-5066	.	_

Text=Participants were debriefed at the end of the scan to find out whether they fell asleep.
35-1	5067-5079	Participants	_
35-2	5080-5084	were	_
35-3	5085-5094	debriefed	_
35-4	5095-5097	at	_
35-5	5098-5101	the	_
35-6	5102-5105	end	_
35-7	5106-5108	of	_
35-8	5109-5112	the	_
35-9	5113-5117	scan	_
35-10	5118-5120	to	_
35-11	5121-5125	find	_
35-12	5126-5129	out	_
35-13	5130-5137	whether	_
35-14	5138-5142	they	_
35-15	5143-5147	fell	_
35-16	5148-5154	asleep	_
35-17	5155-5156	.	_

Text=DTI images were acquired axially using a dual spin echo, single-shot pulsed-gradient echo-planar imaging (EPI) technique.
36-1	5157-5160	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
36-2	5161-5167	images	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
36-3	5168-5172	were	_
36-4	5173-5181	acquired	_
36-5	5182-5189	axially	_
36-6	5190-5195	using	_
36-7	5196-5197	a	_
36-8	5198-5202	dual	_
36-9	5203-5207	spin	_
36-10	5208-5212	echo	_
36-11	5213-5214	,	_
36-12	5215-5226	single-shot	_
36-13	5227-5242	pulsed-gradient	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
36-14	5243-5254	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
36-15	5255-5262	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
36-16	5263-5264	(	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
36-17	5265-5268	EPI	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
36-18	5269-5270	)	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
36-19	5271-5280	technique	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
36-20	5281-5282	.	_

Text=The sequence included a TR of 8.3 s, TE of 86 ms, b-value of 1000 s/mm2, 2 averages, and consisted of 64 slices with a voxel size of 2 × 2 × 2 mm, a field of view of 256 mm, a skip of 0 mm, and 30 non-collinear directions.
37-1	5283-5286	The	_
37-2	5287-5295	sequence	_
37-3	5296-5304	included	_
37-4	5305-5306	a	_
37-5	5307-5309	TR	_
37-6	5310-5312	of	_
37-7	5313-5316	8.3	_
37-8	5317-5318	s	_
37-9	5319-5320	,	_
37-10	5321-5323	TE	_
37-11	5324-5326	of	_
37-12	5327-5329	86	_
37-13	5330-5332	ms	_
37-14	5333-5334	,	_
37-15	5335-5342	b-value	_
37-16	5343-5345	of	_
37-17	5346-5350	1000	_
37-18	5351-5356	s/mm2	_
37-19	5357-5358	,	_
37-20	5359-5360	2	_
37-21	5361-5369	averages	_
37-22	5370-5371	,	_
37-23	5372-5375	and	_
37-24	5376-5385	consisted	_
37-25	5386-5388	of	_
37-26	5389-5391	64	_
37-27	5392-5398	slices	_
37-28	5399-5403	with	_
37-29	5404-5405	a	_
37-30	5406-5411	voxel	_
37-31	5412-5416	size	_
37-32	5417-5419	of	_
37-33	5420-5421	2	_
37-34	5422-5423	×	_
37-35	5424-5425	2	_
37-36	5426-5427	×	_
37-37	5428-5429	2	_
37-38	5430-5432	mm	_
37-39	5433-5434	,	_
37-40	5435-5436	a	_
37-41	5437-5442	field	_
37-42	5443-5445	of	_
37-43	5446-5450	view	_
37-44	5451-5453	of	_
37-45	5454-5457	256	_
37-46	5458-5460	mm	_
37-47	5461-5462	,	_
37-48	5463-5464	a	_
37-49	5465-5469	skip	_
37-50	5470-5472	of	_
37-51	5473-5474	0	_
37-52	5475-5477	mm	_
37-53	5478-5479	,	_
37-54	5480-5483	and	_
37-55	5484-5486	30	_
37-56	5487-5500	non-collinear	_
37-57	5501-5511	directions	_
37-58	5512-5513	.	_

Text=To measure brain structure, we employed a high-res T1 weighted anatomical image that utilized a magnetization prepared rapid gradient-echo sequence.
38-1	5514-5516	To	_
38-2	5517-5524	measure	_
38-3	5525-5530	brain	_
38-4	5531-5540	structure	_
38-5	5541-5542	,	_
38-6	5543-5545	we	_
38-7	5546-5554	employed	_
38-8	5555-5556	a	_
38-9	5557-5565	high-res	_
38-10	5566-5568	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-11	5569-5577	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-12	5578-5588	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-13	5589-5594	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-14	5595-5599	that	_
38-15	5600-5608	utilized	_
38-16	5609-5610	a	_
38-17	5611-5624	magnetization	_
38-18	5625-5633	prepared	_
38-19	5634-5639	rapid	_
38-20	5640-5653	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
38-21	5654-5662	sequence	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
38-22	5663-5664	.	_

Text=A field map was also generated and included a TR of 300 ms, TE of 1.91 ms/4.37 ms, a flip angle of 55°, and a voxel size of 3.4 × 3.4 × 4.0 mm.
39-1	5665-5666	A	_
39-2	5667-5672	field	_
39-3	5673-5676	map	_
39-4	5677-5680	was	_
39-5	5681-5685	also	_
39-6	5686-5695	generated	_
39-7	5696-5699	and	_
39-8	5700-5708	included	_
39-9	5709-5710	a	_
39-10	5711-5713	TR	_
39-11	5714-5716	of	_
39-12	5717-5720	300	_
39-13	5721-5723	ms	_
39-14	5724-5725	,	_
39-15	5726-5728	TE	_
39-16	5729-5731	of	_
39-17	5732-5736	1.91	_
39-18	5737-5744	ms/4.37	_
39-19	5745-5747	ms	_
39-20	5748-5749	,	_
39-21	5750-5751	a	_
39-22	5752-5756	flip	_
39-23	5757-5762	angle	_
39-24	5763-5765	of	_
39-25	5766-5769	55°	_
39-26	5770-5771	,	_
39-27	5772-5775	and	_
39-28	5776-5777	a	_
39-29	5778-5783	voxel	_
39-30	5784-5788	size	_
39-31	5789-5791	of	_
39-32	5792-5795	3.4	_
39-33	5796-5797	×	_
39-34	5798-5801	3.4	_
39-35	5802-5803	×	_
39-36	5804-5807	4.0	_
39-37	5808-5810	mm	_
39-38	5811-5812	.	_

Text=Pre-processing All images were pre-processed to reduce noise from motion and inhomogeneity in the magnetic field, and to produce connectivity matrices for later analysis.
40-1	5813-5827	Pre-processing	_
40-2	5828-5831	All	_
40-3	5832-5838	images	_
40-4	5839-5843	were	_
40-5	5844-5857	pre-processed	_
40-6	5858-5860	to	_
40-7	5861-5867	reduce	_
40-8	5868-5873	noise	_
40-9	5874-5878	from	_
40-10	5879-5885	motion	_
40-11	5886-5889	and	_
40-12	5890-5903	inhomogeneity	_
40-13	5904-5906	in	_
40-14	5907-5910	the	_
40-15	5911-5919	magnetic	_
40-16	5920-5925	field	_
40-17	5926-5927	,	_
40-18	5928-5931	and	_
40-19	5932-5934	to	_
40-20	5935-5942	produce	_
40-21	5943-5955	connectivity	_
40-22	5956-5964	matrices	_
40-23	5965-5968	for	_
40-24	5969-5974	later	_
40-25	5975-5983	analysis	_
40-26	5984-5985	.	_

Text=All fMRI and DTI images were registered to high resolution anatomical space.
41-1	5986-5989	All	_
41-2	5990-5994	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
41-3	5995-5998	and	_
41-4	5999-6002	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
41-5	6003-6009	images	_
41-6	6010-6014	were	_
41-7	6015-6025	registered	_
41-8	6026-6028	to	_
41-9	6029-6033	high	_
41-10	6034-6044	resolution	_
41-11	6045-6055	anatomical	_
41-12	6056-6061	space	_
41-13	6062-6063	.	_

Text=Careful attention was paid to motion correction since subtle movements have been shown to introduce spurious correlations between time series.
42-1	6064-6071	Careful	_
42-2	6072-6081	attention	_
42-3	6082-6085	was	_
42-4	6086-6090	paid	_
42-5	6091-6093	to	_
42-6	6094-6100	motion	_
42-7	6101-6111	correction	_
42-8	6112-6117	since	_
42-9	6118-6124	subtle	_
42-10	6125-6134	movements	_
42-11	6135-6139	have	_
42-12	6140-6144	been	_
42-13	6145-6150	shown	_
42-14	6151-6153	to	_
42-15	6154-6163	introduce	_
42-16	6164-6172	spurious	_
42-17	6173-6185	correlations	_
42-18	6186-6193	between	_
42-19	6194-6198	time	_
42-20	6199-6205	series	_
42-21	6206-6207	.	_

Text=Importantly, the two groups had similar mean root mean square (RMS) motion parameters for the fMRI acquisitions: two-sample t-tests of mean RMS translational and angular movement were not significant (p = 0.14 and p = 0.12, respectively).
43-1	6208-6219	Importantly	_
43-2	6220-6221	,	_
43-3	6222-6225	the	_
43-4	6226-6229	two	_
43-5	6230-6236	groups	_
43-6	6237-6240	had	_
43-7	6241-6248	similar	_
43-8	6249-6253	mean	_
43-9	6254-6258	root	_
43-10	6259-6263	mean	_
43-11	6264-6270	square	_
43-12	6271-6272	(	_
43-13	6273-6276	RMS	_
43-14	6277-6278	)	_
43-15	6279-6285	motion	_
43-16	6286-6296	parameters	_
43-17	6297-6300	for	_
43-18	6301-6304	the	_
43-19	6305-6309	fMRI	_
43-20	6310-6322	acquisitions	_
43-21	6323-6324	:	_
43-22	6325-6335	two-sample	_
43-23	6336-6343	t-tests	_
43-24	6344-6346	of	_
43-25	6347-6351	mean	_
43-26	6352-6355	RMS	_
43-27	6356-6369	translational	_
43-28	6370-6373	and	_
43-29	6374-6381	angular	_
43-30	6382-6390	movement	_
43-31	6391-6395	were	_
43-32	6396-6399	not	_
43-33	6400-6411	significant	_
43-34	6412-6413	(	_
43-35	6414-6415	p	_
43-36	6416-6417	=	_
43-37	6418-6422	0.14	_
43-38	6423-6426	and	_
43-39	6427-6428	p	_
43-40	6429-6430	=	_
43-41	6431-6435	0.12	_
43-42	6436-6437	,	_
43-43	6438-6450	respectively	_
43-44	6451-6452	)	_
43-45	6453-6454	.	_

Text=fMRI images were processed by removing the first 3 volumes for magnetization stabilization, correcting motion artifacts using FSL, correcting for geometric distortion, correcting for slice-timing effects, and removing non-brain elements such as skull, meninges, and dura.
44-1	6455-6459	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
44-2	6460-6466	images	_
44-3	6467-6471	were	_
44-4	6472-6481	processed	_
44-5	6482-6484	by	_
44-6	6485-6493	removing	_
44-7	6494-6497	the	_
44-8	6498-6503	first	_
44-9	6504-6505	3	_
44-10	6506-6513	volumes	_
44-11	6514-6517	for	_
44-12	6518-6531	magnetization	_
44-13	6532-6545	stabilization	_
44-14	6546-6547	,	_
44-15	6548-6558	correcting	_
44-16	6559-6565	motion	_
44-17	6566-6575	artifacts	_
44-18	6576-6581	using	_
44-19	6582-6585	FSL	_
44-20	6586-6587	,	_
44-21	6588-6598	correcting	_
44-22	6599-6602	for	_
44-23	6603-6612	geometric	_
44-24	6613-6623	distortion	_
44-25	6624-6625	,	_
44-26	6626-6636	correcting	_
44-27	6637-6640	for	_
44-28	6641-6653	slice-timing	_
44-29	6654-6661	effects	_
44-30	6662-6663	,	_
44-31	6664-6667	and	_
44-32	6668-6676	removing	_
44-33	6677-6686	non-brain	_
44-34	6687-6695	elements	_
44-35	6696-6700	such	_
44-36	6701-6703	as	_
44-37	6704-6709	skull	_
44-38	6710-6711	,	_
44-39	6712-6720	meninges	_
44-40	6721-6722	,	_
44-41	6723-6726	and	_
44-42	6727-6731	dura	_
44-43	6732-6733	.	_

Text=Spatial smoothing, using a 6 mm full-width half-max kernel, grand mean and intensity normalization, and high-pass temporal filtering were also applied to images.
45-1	6734-6741	Spatial	_
45-2	6742-6751	smoothing	_
45-3	6752-6753	,	_
45-4	6754-6759	using	_
45-5	6760-6761	a	_
45-6	6762-6763	6	_
45-7	6764-6766	mm	_
45-8	6767-6777	full-width	_
45-9	6778-6786	half-max	_
45-10	6787-6793	kernel	_
45-11	6794-6795	,	_
45-12	6796-6801	grand	_
45-13	6802-6806	mean	_
45-14	6807-6810	and	_
45-15	6811-6820	intensity	_
45-16	6821-6834	normalization	_
45-17	6835-6836	,	_
45-18	6837-6840	and	_
45-19	6841-6850	high-pass	_
45-20	6851-6859	temporal	_
45-21	6860-6869	filtering	_
45-22	6870-6874	were	_
45-23	6875-6879	also	_
45-24	6880-6887	applied	_
45-25	6888-6890	to	_
45-26	6891-6897	images	_
45-27	6898-6899	.	_

Text=fMRI images were denoised using probabilistic independent component analysis (PICA) using a tool in FSL (http: //www.fmrib.ox.ac.uk/fsl/), which was based on the procedure established by.
46-1	6900-6904	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
46-2	6905-6911	images	_
46-3	6912-6916	were	_
46-4	6917-6925	denoised	_
46-5	6926-6931	using	_
46-6	6932-6945	probabilistic	_
46-7	6946-6957	independent	_
46-8	6958-6967	component	_
46-9	6968-6976	analysis	_
46-10	6977-6978	(	_
46-11	6979-6983	PICA	_
46-12	6984-6985	)	_
46-13	6986-6991	using	_
46-14	6992-6993	a	_
46-15	6994-6998	tool	_
46-16	6999-7001	in	_
46-17	7002-7005	FSL	_
46-18	7006-7007	(	_
46-19	7008-7012	http	_
46-20	7013-7014	:	_
46-21	7015-7040	//www.fmrib.ox.ac.uk/fsl/	_
46-22	7041-7042	)	_
46-23	7043-7044	,	_
46-24	7045-7050	which	_
46-25	7051-7054	was	_
46-26	7055-7060	based	_
46-27	7061-7063	on	_
46-28	7064-7067	the	_
46-29	7068-7077	procedure	_
46-30	7078-7089	established	_
46-31	7090-7092	by	_
46-32	7093-7094	.	_

Text=The goal of this procedure was to remove noise components from head motion scanner artifacts, and physiological noise as described by and in the MELODIC manual (http: //www.fmrib.ox.ac.uk/fslcourse/lectures/melodic.pdf).
47-1	7095-7098	The	_
47-2	7099-7103	goal	_
47-3	7104-7106	of	_
47-4	7107-7111	this	_
47-5	7112-7121	procedure	_
47-6	7122-7125	was	_
47-7	7126-7128	to	_
47-8	7129-7135	remove	_
47-9	7136-7141	noise	_
47-10	7142-7152	components	_
47-11	7153-7157	from	_
47-12	7158-7162	head	_
47-13	7163-7169	motion	_
47-14	7170-7177	scanner	_
47-15	7178-7187	artifacts	_
47-16	7188-7189	,	_
47-17	7190-7193	and	_
47-18	7194-7207	physiological	_
47-19	7208-7213	noise	_
47-20	7214-7216	as	_
47-21	7217-7226	described	_
47-22	7227-7229	by	_
47-23	7230-7233	and	_
47-24	7234-7236	in	_
47-25	7237-7240	the	_
47-26	7241-7248	MELODIC	_
47-27	7249-7255	manual	_
47-28	7256-7257	(	_
47-29	7258-7262	http	_
47-30	7263-7264	:	_
47-31	7265-7316	//www.fmrib.ox.ac.uk/fslcourse/lectures/melodic.pdf	_
47-32	7317-7318	)	_
47-33	7319-7320	.	_

Text=Linear regression was performed on each voxel to account for effects of individual subject motion by removing 6 motion parameter time courses.
48-1	7321-7327	Linear	_
48-2	7328-7338	regression	_
48-3	7339-7342	was	_
48-4	7343-7352	performed	_
48-5	7353-7355	on	_
48-6	7356-7360	each	_
48-7	7361-7366	voxel	_
48-8	7367-7369	to	_
48-9	7370-7377	account	_
48-10	7378-7381	for	_
48-11	7382-7389	effects	_
48-12	7390-7392	of	_
48-13	7393-7403	individual	_
48-14	7404-7411	subject	_
48-15	7412-7418	motion	_
48-16	7419-7421	by	_
48-17	7422-7430	removing	_
48-18	7431-7432	6	_
48-19	7433-7439	motion	_
48-20	7440-7449	parameter	_
48-21	7450-7454	time	_
48-22	7455-7462	courses	_
48-23	7463-7464	.	_

Text=After registration to high resolution anatomical space, fMRI images were then registered to Montreal Neurological Institute (MNI) standard space (MNI-152 brain).
49-1	7465-7470	After	_
49-2	7471-7483	registration	_
49-3	7484-7486	to	_
49-4	7487-7491	high	_
49-5	7492-7502	resolution	_
49-6	7503-7513	anatomical	_
49-7	7514-7519	space	_
49-8	7520-7521	,	_
49-9	7522-7526	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
49-10	7527-7533	images	_
49-11	7534-7538	were	_
49-12	7539-7543	then	_
49-13	7544-7554	registered	_
49-14	7555-7557	to	_
49-15	7558-7566	Montreal	_
49-16	7567-7579	Neurological	_
49-17	7580-7589	Institute	_
49-18	7590-7591	(	_
49-19	7592-7595	MNI	_
49-20	7596-7597	)	_
49-21	7598-7606	standard	_
49-22	7607-7612	space	_
49-23	7613-7614	(	_
49-24	7615-7622	MNI-152	_
49-25	7623-7628	brain	_
49-26	7629-7630	)	_
49-27	7631-7632	.	_

Text=Average time series were extracted for 90 cortical and subcortical regions of interest (ROIs) based on the Automated Anatomical Labeling (AAL) atlas.
50-1	7633-7640	Average	_
50-2	7641-7645	time	_
50-3	7646-7652	series	_
50-4	7653-7657	were	_
50-5	7658-7667	extracted	_
50-6	7668-7671	for	_
50-7	7672-7674	90	_
50-8	7675-7683	cortical	_
50-9	7684-7687	and	_
50-10	7688-7699	subcortical	_
50-11	7700-7707	regions	_
50-12	7708-7710	of	_
50-13	7711-7719	interest	_
50-14	7720-7721	(	_
50-15	7722-7726	ROIs	_
50-16	7727-7728	)	_
50-17	7729-7734	based	_
50-18	7735-7737	on	_
50-19	7738-7741	the	_
50-20	7742-7751	Automated	_
50-21	7752-7762	Anatomical	_
50-22	7763-7771	Labeling	_
50-23	7772-7773	(	_
50-24	7774-7777	AAL	_
50-25	7778-7779	)	_
50-26	7780-7785	atlas	_
50-27	7786-7787	.	_

Text=ROIs from the cerebellum and vermis were not included in this analysis.
51-1	7788-7792	ROIs	_
51-2	7793-7797	from	_
51-3	7798-7801	the	_
51-4	7802-7812	cerebellum	_
51-5	7813-7816	and	_
51-6	7817-7823	vermis	_
51-7	7824-7828	were	_
51-8	7829-7832	not	_
51-9	7833-7841	included	_
51-10	7842-7844	in	_
51-11	7845-7849	this	_
51-12	7850-7858	analysis	_
51-13	7859-7860	.	_

Text=We used a maximum overlap discrete wavelet transform to extract time series data from specific frequency bands.
52-1	7861-7863	We	_
52-2	7864-7868	used	_
52-3	7869-7870	a	_
52-4	7871-7878	maximum	_
52-5	7879-7886	overlap	_
52-6	7887-7895	discrete	_
52-7	7896-7903	wavelet	_
52-8	7904-7913	transform	_
52-9	7914-7916	to	_
52-10	7917-7924	extract	_
52-11	7925-7929	time	_
52-12	7930-7936	series	_
52-13	7937-7941	data	_
52-14	7942-7946	from	_
52-15	7947-7955	specific	_
52-16	7956-7965	frequency	_
52-17	7966-7971	bands	_
52-18	7972-7973	.	_

Text=We chose the Daubechies 4 wavelet and extracted level 2 wavelet coefficients for each ROI, corresponding to a frequency range of 0.060–0.125 Hz.
53-1	7974-7976	We	_
53-2	7977-7982	chose	_
53-3	7983-7986	the	_
53-4	7987-7997	Daubechies	_
53-5	7998-7999	4	_
53-6	8000-8007	wavelet	_
53-7	8008-8011	and	_
53-8	8012-8021	extracted	_
53-9	8022-8027	level	_
53-10	8028-8029	2	_
53-11	8030-8037	wavelet	_
53-12	8038-8050	coefficients	_
53-13	8051-8054	for	_
53-14	8055-8059	each	_
53-15	8060-8063	ROI	_
53-16	8064-8065	,	_
53-17	8066-8079	corresponding	_
53-18	8080-8082	to	_
53-19	8083-8084	a	_
53-20	8085-8094	frequency	_
53-21	8095-8100	range	_
53-22	8101-8103	of	_
53-23	8104-8115	0.060–0.125	_
53-24	8116-8118	Hz	_
53-25	8119-8120	.	_

Text=We constructed a functional connectivity matrix by computing Pearson correlation coefficients for each pair of ROI time series.
54-1	8121-8123	We	_
54-2	8124-8135	constructed	_
54-3	8136-8137	a	_
54-4	8138-8148	functional	_
54-5	8149-8161	connectivity	_
54-6	8162-8168	matrix	_
54-7	8169-8171	by	_
54-8	8172-8181	computing	_
54-9	8182-8189	Pearson	_
54-10	8190-8201	correlation	_
54-11	8202-8214	coefficients	_
54-12	8215-8218	for	_
54-13	8219-8223	each	_
54-14	8224-8228	pair	_
54-15	8229-8231	of	_
54-16	8232-8235	ROI	_
54-17	8236-8240	time	_
54-18	8241-8247	series	_
54-19	8248-8249	.	_

Text=DTI images were corrected for distortion due to eddy currents and head motion (using a 6 degrees of freedom linear registration) and were further corrected for geometric distortion using field maps generated during the structural scan.
55-1	8250-8253	DTI	_
55-2	8254-8260	images	_
55-3	8261-8265	were	_
55-4	8266-8275	corrected	_
55-5	8276-8279	for	_
55-6	8280-8290	distortion	_
55-7	8291-8294	due	_
55-8	8295-8297	to	_
55-9	8298-8302	eddy	_
55-10	8303-8311	currents	_
55-11	8312-8315	and	_
55-12	8316-8320	head	_
55-13	8321-8327	motion	_
55-14	8328-8329	(	_
55-15	8330-8335	using	_
55-16	8336-8337	a	_
55-17	8338-8339	6	_
55-18	8340-8347	degrees	_
55-19	8348-8350	of	_
55-20	8351-8358	freedom	_
55-21	8359-8365	linear	_
55-22	8366-8378	registration	_
55-23	8379-8380	)	_
55-24	8381-8384	and	_
55-25	8385-8389	were	_
55-26	8390-8397	further	_
55-27	8398-8407	corrected	_
55-28	8408-8411	for	_
55-29	8412-8421	geometric	_
55-30	8422-8432	distortion	_
55-31	8433-8438	using	_
55-32	8439-8444	field	_
55-33	8445-8449	maps	_
55-34	8450-8459	generated	_
55-35	8460-8466	during	_
55-36	8467-8470	the	_
55-37	8471-8481	structural	_
55-38	8482-8486	scan	_
55-39	8487-8488	.	_

Text=The AAL atlas was then transformed to native space for each subject using a non-linear registration (FNIRT; http: //www.fmrib.ox.ac.uk/fsl/fnirt).
56-1	8489-8492	The	_
56-2	8493-8496	AAL	_
56-3	8497-8502	atlas	_
56-4	8503-8506	was	_
56-5	8507-8511	then	_
56-6	8512-8523	transformed	_
56-7	8524-8526	to	_
56-8	8527-8533	native	_
56-9	8534-8539	space	_
56-10	8540-8543	for	_
56-11	8544-8548	each	_
56-12	8549-8556	subject	_
56-13	8557-8562	using	_
56-14	8563-8564	a	_
56-15	8565-8575	non-linear	_
56-16	8576-8588	registration	_
56-17	8589-8590	(	_
56-18	8591-8596	FNIRT	_
56-19	8597-8598	;	_
56-20	8599-8603	http	_
56-21	8604-8605	:	_
56-22	8606-8636	//www.fmrib.ox.ac.uk/fsl/fnirt	_
56-23	8637-8638	)	_
56-24	8639-8640	.	_

Text=White matter tractography files were generated by a FACT-based, DTI algorithm using the TrackVis Diffusion Toolkit (trackviz.org); parameters included a 35 degree angle threshold, 0.1 step threshold, and voxel center seed location using one seed per voxel, with analysis applied to the whole brain.
57-1	8641-8646	White	_
57-2	8647-8653	matter	_
57-3	8654-8666	tractography	_
57-4	8667-8672	files	_
57-5	8673-8677	were	_
57-6	8678-8687	generated	_
57-7	8688-8690	by	_
57-8	8691-8692	a	_
57-9	8693-8703	FACT-based	_
57-10	8704-8705	,	_
57-11	8706-8709	DTI	_
57-12	8710-8719	algorithm	_
57-13	8720-8725	using	_
57-14	8726-8729	the	_
57-15	8730-8738	TrackVis	_
57-16	8739-8748	Diffusion	_
57-17	8749-8756	Toolkit	_
57-18	8757-8758	(	_
57-19	8759-8771	trackviz.org	_
57-20	8772-8773	)	_
57-21	8774-8775	;	_
57-22	8776-8786	parameters	_
57-23	8787-8795	included	_
57-24	8796-8797	a	_
57-25	8798-8800	35	_
57-26	8801-8807	degree	_
57-27	8808-8813	angle	_
57-28	8814-8823	threshold	_
57-29	8824-8825	,	_
57-30	8826-8829	0.1	_
57-31	8830-8834	step	_
57-32	8835-8844	threshold	_
57-33	8845-8846	,	_
57-34	8847-8850	and	_
57-35	8851-8856	voxel	_
57-36	8857-8863	center	_
57-37	8864-8868	seed	_
57-38	8869-8877	location	_
57-39	8878-8883	using	_
57-40	8884-8887	one	_
57-41	8888-8892	seed	_
57-42	8893-8896	per	_
57-43	8897-8902	voxel	_
57-44	8903-8904	,	_
57-45	8905-8909	with	_
57-46	8910-8918	analysis	_
57-47	8919-8926	applied	_
57-48	8927-8929	to	_
57-49	8930-8933	the	_
57-50	8934-8939	whole	_
57-51	8940-8945	brain	_
57-52	8946-8947	.	_

Text=This algorithm was applied to the whole brain according to the TrackVis Diffusion Toolkit guidelines.
58-1	8948-8952	This	_
58-2	8953-8962	algorithm	_
58-3	8963-8966	was	_
58-4	8967-8974	applied	_
58-5	8975-8977	to	_
58-6	8978-8981	the	_
58-7	8982-8987	whole	_
58-8	8988-8993	brain	_
58-9	8994-9003	according	_
58-10	9004-9006	to	_
58-11	9007-9010	the	_
58-12	9011-9019	TrackVis	_
58-13	9020-9029	Diffusion	_
58-14	9030-9037	Toolkit	_
58-15	9038-9048	guidelines	_
58-16	9049-9050	.	_

Text=We constructed an anatomical connectivity matrix by counting the number of white matter streamlines linking each pair of ROIs, in a similar manner to that reported in.
59-1	9051-9053	We	_
59-2	9054-9065	constructed	_
59-3	9066-9068	an	_
59-4	9069-9079	anatomical	_
59-5	9080-9092	connectivity	_
59-6	9093-9099	matrix	_
59-7	9100-9102	by	_
59-8	9103-9111	counting	_
59-9	9112-9115	the	_
59-10	9116-9122	number	_
59-11	9123-9125	of	_
59-12	9126-9131	white	_
59-13	9132-9138	matter	_
59-14	9139-9150	streamlines	_
59-15	9151-9158	linking	_
59-16	9159-9163	each	_
59-17	9164-9168	pair	_
59-18	9169-9171	of	_
59-19	9172-9176	ROIs	_
59-20	9177-9178	,	_
59-21	9179-9181	in	_
59-22	9182-9183	a	_
59-23	9184-9191	similar	_
59-24	9192-9198	manner	_
59-25	9199-9201	to	_
59-26	9202-9206	that	_
59-27	9207-9215	reported	_
59-28	9216-9218	in	_
59-29	9219-9220	.	_

Text=Brain size analysis Structural T1 volumetric data were processed with FreeSurfer.
60-1	9221-9226	Brain	_
60-2	9227-9231	size	_
60-3	9232-9240	analysis	_
60-4	9241-9251	Structural	_
60-5	9252-9254	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
60-6	9255-9265	volumetric	_
60-7	9266-9270	data	_
60-8	9271-9275	were	_
60-9	9276-9285	processed	_
60-10	9286-9290	with	_
60-11	9291-9301	FreeSurfer	_
60-12	9302-9303	.	_

Text=Using the FreeSurfer BrainSegNotVent variable, we compared brain size between the two groups with age and gender as covariates.
61-1	9304-9309	Using	_
61-2	9310-9313	the	_
61-3	9314-9324	FreeSurfer	_
61-4	9325-9340	BrainSegNotVent	_
61-5	9341-9349	variable	_
61-6	9350-9351	,	_
61-7	9352-9354	we	_
61-8	9355-9363	compared	_
61-9	9364-9369	brain	_
61-10	9370-9374	size	_
61-11	9375-9382	between	_
61-12	9383-9386	the	_
61-13	9387-9390	two	_
61-14	9391-9397	groups	_
61-15	9398-9402	with	_
61-16	9403-9406	age	_
61-17	9407-9410	and	_
61-18	9411-9417	gender	_
61-19	9418-9420	as	_
61-20	9421-9431	covariates	_
61-21	9432-9433	.	_

Text=No significant group difference was found.
62-1	9434-9436	No	_
62-2	9437-9448	significant	_
62-3	9449-9454	group	_
62-4	9455-9465	difference	_
62-5	9466-9469	was	_
62-6	9470-9475	found	_
62-7	9476-9477	.	_

Text=Bivariate analysis As described above, for each data type a 90 × 90 (N × N) connectivity matrix was generated.
63-1	9478-9487	Bivariate	_
63-2	9488-9496	analysis	_
63-3	9497-9499	As	_
63-4	9500-9509	described	_
63-5	9510-9515	above	_
63-6	9516-9517	,	_
63-7	9518-9521	for	_
63-8	9522-9526	each	_
63-9	9527-9531	data	_
63-10	9532-9536	type	_
63-11	9537-9538	a	_
63-12	9539-9541	90	_
63-13	9542-9543	×	_
63-14	9544-9546	90	_
63-15	9547-9548	(	_
63-16	9549-9550	N	_
63-17	9551-9552	×	_
63-18	9553-9554	N	_
63-19	9555-9556	)	_
63-20	9557-9569	connectivity	_
63-21	9570-9576	matrix	_
63-22	9577-9580	was	_
63-23	9581-9590	generated	_
63-24	9591-9592	.	_

Text=This matrix describes the (functional or anatomical) connectivity between pairs of brain regions (4005 pairs in total).
64-1	9593-9597	This	_
64-2	9598-9604	matrix	_
64-3	9605-9614	describes	_
64-4	9615-9618	the	_
64-5	9619-9620	(	_
64-6	9621-9631	functional	_
64-7	9632-9634	or	_
64-8	9635-9645	anatomical	_
64-9	9646-9647	)	_
64-10	9648-9660	connectivity	_
64-11	9661-9668	between	_
64-12	9669-9674	pairs	_
64-13	9675-9677	of	_
64-14	9678-9683	brain	_
64-15	9684-9691	regions	_
64-16	9692-9693	(	_
64-17	9694-9698	4005	_
64-18	9699-9704	pairs	_
64-19	9705-9707	in	_
64-20	9708-9713	total	_
64-21	9714-9715	)	_
64-22	9716-9717	.	_

Text=We then calculated the average connectivity between each region and all 89 other regions.
65-1	9718-9720	We	_
65-2	9721-9725	then	_
65-3	9726-9736	calculated	_
65-4	9737-9740	the	_
65-5	9741-9748	average	_
65-6	9749-9761	connectivity	_
65-7	9762-9769	between	_
65-8	9770-9774	each	_
65-9	9775-9781	region	_
65-10	9782-9785	and	_
65-11	9786-9789	all	_
65-12	9790-9792	89	_
65-13	9793-9798	other	_
65-14	9799-9806	regions	_
65-15	9807-9808	.	_

Text=This measure of connectivity is referred to as regional strength.
66-1	9809-9813	This	_
66-2	9814-9821	measure	_
66-3	9822-9824	of	_
66-4	9825-9837	connectivity	_
66-5	9838-9840	is	_
66-6	9841-9849	referred	_
66-7	9850-9852	to	_
66-8	9853-9855	as	_
66-9	9856-9864	regional	_
66-10	9865-9873	strength	_
66-11	9874-9875	.	_

Text=Specifically, the strength of node (region) i is defined as the mean value of the ith column of the connectivity matrix.
67-1	9876-9888	Specifically	_
67-2	9889-9890	,	_
67-3	9891-9894	the	_
67-4	9895-9903	strength	_
67-5	9904-9906	of	_
67-6	9907-9911	node	_
67-7	9912-9913	(	_
67-8	9914-9920	region	_
67-9	9921-9922	)	_
67-10	9923-9924	i	_
67-11	9925-9927	is	_
67-12	9928-9935	defined	_
67-13	9936-9938	as	_
67-14	9939-9942	the	_
67-15	9943-9947	mean	_
67-16	9948-9953	value	_
67-17	9954-9956	of	_
67-18	9957-9960	the	_
67-19	9961-9964	ith	_
67-20	9965-9971	column	_
67-21	9972-9974	of	_
67-22	9975-9978	the	_
67-23	9979-9991	connectivity	_
67-24	9992-9998	matrix	_
67-25	9999-10000	.	_

Text=Overall brain connectivity, referred to as the global strength, was then calculated.
68-1	10001-10008	Overall	_
68-2	10009-10014	brain	_
68-3	10015-10027	connectivity	_
68-4	10028-10029	,	_
68-5	10030-10038	referred	_
68-6	10039-10041	to	_
68-7	10042-10044	as	_
68-8	10045-10048	the	_
68-9	10049-10055	global	_
68-10	10056-10064	strength	_
68-11	10065-10066	,	_
68-12	10067-10070	was	_
68-13	10071-10075	then	_
68-14	10076-10086	calculated	_
68-15	10087-10088	.	_

Text=Specifically, the global strength was calculated by averaging all regional strengths into one value.
69-1	10089-10101	Specifically	_
69-2	10102-10103	,	_
69-3	10104-10107	the	_
69-4	10108-10114	global	_
69-5	10115-10123	strength	_
69-6	10124-10127	was	_
69-7	10128-10138	calculated	_
69-8	10139-10141	by	_
69-9	10142-10151	averaging	_
69-10	10152-10155	all	_
69-11	10156-10164	regional	_
69-12	10165-10174	strengths	_
69-13	10175-10179	into	_
69-14	10180-10183	one	_
69-15	10184-10189	value	_
69-16	10190-10191	.	_

Text=Group comparisons were made for both anatomical and functional data types and for both regional and global strength measures.
70-1	10192-10197	Group	_
70-2	10198-10209	comparisons	_
70-3	10210-10214	were	_
70-4	10215-10219	made	_
70-5	10220-10223	for	_
70-6	10224-10228	both	_
70-7	10229-10239	anatomical	_
70-8	10240-10243	and	_
70-9	10244-10254	functional	_
70-10	10255-10259	data	_
70-11	10260-10265	types	_
70-12	10266-10269	and	_
70-13	10270-10273	for	_
70-14	10274-10278	both	_
70-15	10279-10287	regional	_
70-16	10288-10291	and	_
70-17	10292-10298	global	_
70-18	10299-10307	strength	_
70-19	10308-10316	measures	_
70-20	10317-10318	.	_

Text=Comparisons were calculated via an independent two sample t-statistic.
71-1	10319-10330	Comparisons	_
71-2	10331-10335	were	_
71-3	10336-10346	calculated	_
71-4	10347-10350	via	_
71-5	10351-10353	an	_
71-6	10354-10365	independent	_
71-7	10366-10369	two	_
71-8	10370-10376	sample	_
71-9	10377-10388	t-statistic	_
71-10	10389-10390	.	_

Text=This was calculated as the mean group difference divided by the pooled standard deviation.
72-1	10391-10395	This	_
72-2	10396-10399	was	_
72-3	10400-10410	calculated	_
72-4	10411-10413	as	_
72-5	10414-10417	the	_
72-6	10418-10422	mean	_
72-7	10423-10428	group	_
72-8	10429-10439	difference	_
72-9	10440-10447	divided	_
72-10	10448-10450	by	_
72-11	10451-10454	the	_
72-12	10455-10461	pooled	_
72-13	10462-10470	standard	_
72-14	10471-10480	deviation	_
72-15	10481-10482	.	_

Text=Significance was tested by permutation testing.
73-1	10483-10495	Significance	_
73-2	10496-10499	was	_
73-3	10500-10506	tested	_
73-4	10507-10509	by	_
73-5	10510-10521	permutation	_
73-6	10522-10529	testing	_
73-7	10530-10531	.	_

Text=Ten million random permutations were performed for regional and global strength for both anatomical and functional data.
74-1	10532-10535	Ten	_
74-2	10536-10543	million	_
74-3	10544-10550	random	_
74-4	10551-10563	permutations	_
74-5	10564-10568	were	_
74-6	10569-10578	performed	_
74-7	10579-10582	for	_
74-8	10583-10591	regional	_
74-9	10592-10595	and	_
74-10	10596-10602	global	_
74-11	10603-10611	strength	_
74-12	10612-10615	for	_
74-13	10616-10620	both	_
74-14	10621-10631	anatomical	_
74-15	10632-10635	and	_
74-16	10636-10646	functional	_
74-17	10647-10651	data	_
74-18	10652-10653	.	_

Text=For each permutation, group labels were randomized and a t-statistic was calculated.
75-1	10654-10657	For	_
75-2	10658-10662	each	_
75-3	10663-10674	permutation	_
75-4	10675-10676	,	_
75-5	10677-10682	group	_
75-6	10683-10689	labels	_
75-7	10690-10694	were	_
75-8	10695-10705	randomized	_
75-9	10706-10709	and	_
75-10	10710-10711	a	_
75-11	10712-10723	t-statistic	_
75-12	10724-10727	was	_
75-13	10728-10738	calculated	_
75-14	10739-10740	.	_

Text=This t-statistic extracted from the permuted data was then included as a member of the null distribution.
76-1	10741-10745	This	_
76-2	10746-10757	t-statistic	_
76-3	10758-10767	extracted	_
76-4	10768-10772	from	_
76-5	10773-10776	the	_
76-6	10777-10785	permuted	_
76-7	10786-10790	data	_
76-8	10791-10794	was	_
76-9	10795-10799	then	_
76-10	10800-10808	included	_
76-11	10809-10811	as	_
76-12	10812-10813	a	_
76-13	10814-10820	member	_
76-14	10821-10823	of	_
76-15	10824-10827	the	_
76-16	10828-10832	null	_
76-17	10833-10845	distribution	_
76-18	10846-10847	.	_

Text=The position of the true t-statistic was then located in the null distribution to determine a p-value.
77-1	10848-10851	The	_
77-2	10852-10860	position	_
77-3	10861-10863	of	_
77-4	10864-10867	the	_
77-5	10868-10872	true	_
77-6	10873-10884	t-statistic	_
77-7	10885-10888	was	_
77-8	10889-10893	then	_
77-9	10894-10901	located	_
77-10	10902-10904	in	_
77-11	10905-10908	the	_
77-12	10909-10913	null	_
77-13	10914-10926	distribution	_
77-14	10927-10929	to	_
77-15	10930-10939	determine	_
77-16	10940-10941	a	_
77-17	10942-10949	p-value	_
77-18	10950-10951	.	_

Text=The p-value was calculated by dividing the count of null t-statistic values larger than the true t-statistic by the total number of permutations.
78-1	10952-10955	The	_
78-2	10956-10963	p-value	_
78-3	10964-10967	was	_
78-4	10968-10978	calculated	_
78-5	10979-10981	by	_
78-6	10982-10990	dividing	_
78-7	10991-10994	the	_
78-8	10995-11000	count	_
78-9	11001-11003	of	_
78-10	11004-11008	null	_
78-11	11009-11020	t-statistic	_
78-12	11021-11027	values	_
78-13	11028-11034	larger	_
78-14	11035-11039	than	_
78-15	11040-11043	the	_
78-16	11044-11048	true	_
78-17	11049-11060	t-statistic	_
78-18	11061-11063	by	_
78-19	11064-11067	the	_
78-20	11068-11073	total	_
78-21	11074-11080	number	_
78-22	11081-11083	of	_
78-23	11084-11096	permutations	_
78-24	11097-11098	.	_

Text=Control for Type-I (false positive) errors that accompany multiple comparisons, specifically for the regional analysis, was then performed using a false discovery rate (FDR) correction.
79-1	11099-11106	Control	_
79-2	11107-11110	for	_
79-3	11111-11117	Type-I	_
79-4	11118-11119	(	_
79-5	11120-11125	false	_
79-6	11126-11134	positive	_
79-7	11135-11136	)	_
79-8	11137-11143	errors	_
79-9	11144-11148	that	_
79-10	11149-11158	accompany	_
79-11	11159-11167	multiple	_
79-12	11168-11179	comparisons	_
79-13	11180-11181	,	_
79-14	11182-11194	specifically	_
79-15	11195-11198	for	_
79-16	11199-11202	the	_
79-17	11203-11211	regional	_
79-18	11212-11220	analysis	_
79-19	11221-11222	,	_
79-20	11223-11226	was	_
79-21	11227-11231	then	_
79-22	11232-11241	performed	_
79-23	11242-11247	using	_
79-24	11248-11249	a	_
79-25	11250-11255	false	_
79-26	11256-11265	discovery	_
79-27	11266-11270	rate	_
79-28	11271-11272	(	_
79-29	11273-11276	FDR	_
79-30	11277-11278	)	_
79-31	11279-11289	correction	_
79-32	11290-11291	.	_

Text=Network analysis Here we used the Network-Based Statistic (NBS) developed by to determine group differences in connectivity within each imaging modality.
80-1	11292-11299	Network	_
80-2	11300-11308	analysis	_
80-3	11309-11313	Here	_
80-4	11314-11316	we	_
80-5	11317-11321	used	_
80-6	11322-11325	the	_
80-7	11326-11339	Network-Based	_
80-8	11340-11349	Statistic	_
80-9	11350-11351	(	_
80-10	11352-11355	NBS	_
80-11	11356-11357	)	_
80-12	11358-11367	developed	_
80-13	11368-11370	by	_
80-14	11371-11373	to	_
80-15	11374-11383	determine	_
80-16	11384-11389	group	_
80-17	11390-11401	differences	_
80-18	11402-11404	in	_
80-19	11405-11417	connectivity	_
80-20	11418-11424	within	_
80-21	11425-11429	each	_
80-22	11430-11437	imaging	_
80-23	11438-11446	modality	_
80-24	11447-11448	.	_

Text=In a second-level analysis, we evaluated the overlap of significantly different, connected ROIs between modalities using a multimodal extension NBSm which we develop for this study.
81-1	11449-11451	In	_
81-2	11452-11453	a	_
81-3	11454-11466	second-level	_
81-4	11467-11475	analysis	_
81-5	11476-11477	,	_
81-6	11478-11480	we	_
81-7	11481-11490	evaluated	_
81-8	11491-11494	the	_
81-9	11495-11502	overlap	_
81-10	11503-11505	of	_
81-11	11506-11519	significantly	_
81-12	11520-11529	different	_
81-13	11530-11531	,	_
81-14	11532-11541	connected	_
81-15	11542-11546	ROIs	_
81-16	11547-11554	between	_
81-17	11555-11565	modalities	_
81-18	11566-11571	using	_
81-19	11572-11573	a	_
81-20	11574-11584	multimodal	_
81-21	11585-11594	extension	_
81-22	11595-11599	NBSm	_
81-23	11600-11605	which	_
81-24	11606-11608	we	_
81-25	11609-11616	develop	_
81-26	11617-11620	for	_
81-27	11621-11625	this	_
81-28	11626-11631	study	_
81-29	11632-11633	.	_

Text=Intramodal differences (NBS) Subjects were labeled as proband or control and group differences between matrix elements were identified by generating a t-statistic for each element in the connectivity matrices.
82-1	11634-11644	Intramodal	_
82-2	11645-11656	differences	_
82-3	11657-11658	(	_
82-4	11659-11662	NBS	_
82-5	11663-11664	)	_
82-6	11665-11673	Subjects	_
82-7	11674-11678	were	_
82-8	11679-11686	labeled	_
82-9	11687-11689	as	_
82-10	11690-11697	proband	_
82-11	11698-11700	or	_
82-12	11701-11708	control	_
82-13	11709-11712	and	_
82-14	11713-11718	group	_
82-15	11719-11730	differences	_
82-16	11731-11738	between	_
82-17	11739-11745	matrix	_
82-18	11746-11754	elements	_
82-19	11755-11759	were	_
82-20	11760-11770	identified	_
82-21	11771-11773	by	_
82-22	11774-11784	generating	_
82-23	11785-11786	a	_
82-24	11787-11798	t-statistic	_
82-25	11799-11802	for	_
82-26	11803-11807	each	_
82-27	11808-11815	element	_
82-28	11816-11818	in	_
82-29	11819-11822	the	_
82-30	11823-11835	connectivity	_
82-31	11836-11844	matrices	_
82-32	11845-11846	.	_

Text=In this way, we constructed a t-matrix representing group differences in connection strengths for each modality.
83-1	11847-11849	In	_
83-2	11850-11854	this	_
83-3	11855-11858	way	_
83-4	11859-11860	,	_
83-5	11861-11863	we	_
83-6	11864-11875	constructed	_
83-7	11876-11877	a	_
83-8	11878-11886	t-matrix	_
83-9	11887-11899	representing	_
83-10	11900-11905	group	_
83-11	11906-11917	differences	_
83-12	11918-11920	in	_
83-13	11921-11931	connection	_
83-14	11932-11941	strengths	_
83-15	11942-11945	for	_
83-16	11946-11950	each	_
83-17	11951-11959	modality	_
83-18	11960-11961	.	_

Text=The t-matrix for each modality was thresholded to retain information only for matrix elements with the largest group differences.
84-1	11962-11965	The	_
84-2	11966-11974	t-matrix	_
84-3	11975-11978	for	_
84-4	11979-11983	each	_
84-5	11984-11992	modality	_
84-6	11993-11996	was	_
84-7	11997-12008	thresholded	_
84-8	12009-12011	to	_
84-9	12012-12018	retain	_
84-10	12019-12030	information	_
84-11	12031-12035	only	_
84-12	12036-12039	for	_
84-13	12040-12046	matrix	_
84-14	12047-12055	elements	_
84-15	12056-12060	with	_
84-16	12061-12064	the	_
84-17	12065-12072	largest	_
84-18	12073-12078	group	_
84-19	12079-12090	differences	_
84-20	12091-12092	.	_

Text=An initial data exploration was performed to find the t-threshold for each data modality.
85-1	12093-12095	An	_
85-2	12096-12103	initial	_
85-3	12104-12108	data	_
85-4	12109-12120	exploration	_
85-5	12121-12124	was	_
85-6	12125-12134	performed	_
85-7	12135-12137	to	_
85-8	12138-12142	find	_
85-9	12143-12146	the	_
85-10	12147-12158	t-threshold	_
85-11	12159-12162	for	_
85-12	12163-12167	each	_
85-13	12168-12172	data	_
85-14	12173-12181	modality	_
85-15	12182-12183	.	_

Text=A distribution of node count (of the largest component) versus t-threshold was generated for each modality over a wide range of possible t-thresholds.
86-1	12184-12185	A	_
86-2	12186-12198	distribution	_
86-3	12199-12201	of	_
86-4	12202-12206	node	_
86-5	12207-12212	count	_
86-6	12213-12214	(	_
86-7	12215-12217	of	_
86-8	12218-12221	the	_
86-9	12222-12229	largest	_
86-10	12230-12239	component	_
86-11	12240-12241	)	_
86-12	12242-12248	versus	_
86-13	12249-12260	t-threshold	_
86-14	12261-12264	was	_
86-15	12265-12274	generated	_
86-16	12275-12278	for	_
86-17	12279-12283	each	_
86-18	12284-12292	modality	_
86-19	12293-12297	over	_
86-20	12298-12299	a	_
86-21	12300-12304	wide	_
86-22	12305-12310	range	_
86-23	12311-12313	of	_
86-24	12314-12322	possible	_
86-25	12323-12335	t-thresholds	_
86-26	12336-12337	.	_

Text=Since the anatomical imaging had a lower distribution of t-thresholds it was used to choose a maximal node count provided by a t-threshold ≥ 2.00 (Fig.
87-1	12338-12343	Since	_
87-2	12344-12347	the	_
87-3	12348-12358	anatomical	_
87-4	12359-12366	imaging	_
87-5	12367-12370	had	_
87-6	12371-12372	a	_
87-7	12373-12378	lower	_
87-8	12379-12391	distribution	_
87-9	12392-12394	of	_
87-10	12395-12407	t-thresholds	_
87-11	12408-12410	it	_
87-12	12411-12414	was	_
87-13	12415-12419	used	_
87-14	12420-12422	to	_
87-15	12423-12429	choose	_
87-16	12430-12431	a	_
87-17	12432-12439	maximal	_
87-18	12440-12444	node	_
87-19	12445-12450	count	_
87-20	12451-12459	provided	_
87-21	12460-12462	by	_
87-22	12463-12464	a	_
87-23	12465-12476	t-threshold	_
87-24	12477-12478	≥	_
87-25	12479-12483	2.00	_
87-26	12484-12485	(	_
87-27	12486-12489	Fig	_
87-28	12490-12491	.	_

Text=1) and resulted in a t-threshold of 2.10.
88-1	12492-12493	1	_
88-2	12494-12495	)	_
88-3	12496-12499	and	_
88-4	12500-12508	resulted	_
88-5	12509-12511	in	_
88-6	12512-12513	a	_
88-7	12514-12525	t-threshold	_
88-8	12526-12528	of	_
88-9	12529-12533	2.10	_
88-10	12534-12535	.	_

Text=Based on node count this resulted in the selection of a functional t-threshold of 5.00.
89-1	12536-12541	Based	_
89-2	12542-12544	on	_
89-3	12545-12549	node	_
89-4	12550-12555	count	_
89-5	12556-12560	this	_
89-6	12561-12569	resulted	_
89-7	12570-12572	in	_
89-8	12573-12576	the	_
89-9	12577-12586	selection	_
89-10	12587-12589	of	_
89-11	12590-12591	a	_
89-12	12592-12602	functional	_
89-13	12603-12614	t-threshold	_
89-14	12615-12617	of	_
89-15	12618-12622	5.00	_
89-16	12623-12624	.	_

Text=This method provided similarly sized components even within very different imaging modalities.
90-1	12625-12629	This	_
90-2	12630-12636	method	_
90-3	12637-12645	provided	_
90-4	12646-12655	similarly	_
90-5	12656-12661	sized	_
90-6	12662-12672	components	_
90-7	12673-12677	even	_
90-8	12678-12684	within	_
90-9	12685-12689	very	_
90-10	12690-12699	different	_
90-11	12700-12707	imaging	_
90-12	12708-12718	modalities	_
90-13	12719-12720	.	_

Text=Once a t-threshold was chosen for each modality, each t-matrix was thresholded and subnetworks were identified.
91-1	12721-12725	Once	_
91-2	12726-12727	a	_
91-3	12728-12739	t-threshold	_
91-4	12740-12743	was	_
91-5	12744-12750	chosen	_
91-6	12751-12754	for	_
91-7	12755-12759	each	_
91-8	12760-12768	modality	_
91-9	12769-12770	,	_
91-10	12771-12775	each	_
91-11	12776-12784	t-matrix	_
91-12	12785-12788	was	_
91-13	12789-12800	thresholded	_
91-14	12801-12804	and	_
91-15	12805-12816	subnetworks	_
91-16	12817-12821	were	_
91-17	12822-12832	identified	_
91-18	12833-12834	.	_

Text=The largest intramodal component was defined as the subnetwork of the modality-specific t-matrix with the largest total number of edges.
92-1	12835-12838	The	_
92-2	12839-12846	largest	_
92-3	12847-12857	intramodal	_
92-4	12858-12867	component	_
92-5	12868-12871	was	_
92-6	12872-12879	defined	_
92-7	12880-12882	as	_
92-8	12883-12886	the	_
92-9	12887-12897	subnetwork	_
92-10	12898-12900	of	_
92-11	12901-12904	the	_
92-12	12905-12922	modality-specific	_
92-13	12923-12931	t-matrix	_
92-14	12932-12936	with	_
92-15	12937-12940	the	_
92-16	12941-12948	largest	_
92-17	12949-12954	total	_
92-18	12955-12961	number	_
92-19	12962-12964	of	_
92-20	12965-12970	edges	_
92-21	12971-12972	.	_

Text=In short, we use the size of the largest connected component as a statistic; noting that this sub-graph isolates significant network-based differences between the two groups.
93-1	12973-12975	In	_
93-2	12976-12981	short	_
93-3	12982-12983	,	_
93-4	12984-12986	we	_
93-5	12987-12990	use	_
93-6	12991-12994	the	_
93-7	12995-12999	size	_
93-8	13000-13002	of	_
93-9	13003-13006	the	_
93-10	13007-13014	largest	_
93-11	13015-13024	connected	_
93-12	13025-13034	component	_
93-13	13035-13037	as	_
93-14	13038-13039	a	_
93-15	13040-13049	statistic	_
93-16	13050-13051	;	_
93-17	13052-13058	noting	_
93-18	13059-13063	that	_
93-19	13064-13068	this	_
93-20	13069-13078	sub-graph	_
93-21	13079-13087	isolates	_
93-22	13088-13099	significant	_
93-23	13100-13113	network-based	_
93-24	13114-13125	differences	_
93-25	13126-13133	between	_
93-26	13134-13137	the	_
93-27	13138-13141	two	_
93-28	13142-13148	groups	_
93-29	13149-13150	.	_

Text=In other words, we are testing against the null hypothesis that the size of a sub-graph of group differences is larger than expected by chance.
94-1	13151-13153	In	_
94-2	13154-13159	other	_
94-3	13160-13165	words	_
94-4	13166-13167	,	_
94-5	13168-13170	we	_
94-6	13171-13174	are	_
94-7	13175-13182	testing	_
94-8	13183-13190	against	_
94-9	13191-13194	the	_
94-10	13195-13199	null	_
94-11	13200-13210	hypothesis	_
94-12	13211-13215	that	_
94-13	13216-13219	the	_
94-14	13220-13224	size	_
94-15	13225-13227	of	_
94-16	13228-13229	a	_
94-17	13230-13239	sub-graph	_
94-18	13240-13242	of	_
94-19	13243-13248	group	_
94-20	13249-13260	differences	_
94-21	13261-13263	is	_
94-22	13264-13270	larger	_
94-23	13271-13275	than	_
94-24	13276-13284	expected	_
94-25	13285-13287	by	_
94-26	13288-13294	chance	_
94-27	13295-13296	.	_

Text=NBS significance testing The significance of intra-modal components was tested using a permutation testing technique (Fig.
95-1	13297-13300	NBS	_
95-2	13301-13313	significance	_
95-3	13314-13321	testing	_
95-4	13322-13325	The	_
95-5	13326-13338	significance	_
95-6	13339-13341	of	_
95-7	13342-13353	intra-modal	_
95-8	13354-13364	components	_
95-9	13365-13368	was	_
95-10	13369-13375	tested	_
95-11	13376-13381	using	_
95-12	13382-13383	a	_
95-13	13384-13395	permutation	_
95-14	13396-13403	testing	_
95-15	13404-13413	technique	_
95-16	13414-13415	(	_
95-17	13416-13419	Fig	_
95-18	13420-13421	.	_

Text=2).
96-1	13422-13423	2	_
96-2	13424-13425	)	_
96-3	13426-13427	.	_

Text=The intra-modal component generation process was repeated for each modality with random reassignment of subject labels but with maintenance of original group sizes.
97-1	13428-13431	The	_
97-2	13432-13443	intra-modal	_
97-3	13444-13453	component	_
97-4	13454-13464	generation	_
97-5	13465-13472	process	_
97-6	13473-13476	was	_
97-7	13477-13485	repeated	_
97-8	13486-13489	for	_
97-9	13490-13494	each	_
97-10	13495-13503	modality	_
97-11	13504-13508	with	_
97-12	13509-13515	random	_
97-13	13516-13528	reassignment	_
97-14	13529-13531	of	_
97-15	13532-13539	subject	_
97-16	13540-13546	labels	_
97-17	13547-13550	but	_
97-18	13551-13555	with	_
97-19	13556-13567	maintenance	_
97-20	13568-13570	of	_
97-21	13571-13579	original	_
97-22	13580-13585	group	_
97-23	13586-13591	sizes	_
97-24	13592-13593	.	_

Text=For each random permutation, the maximum component size was calculated and stored in a null intra-modal distribution.
98-1	13594-13597	For	_
98-2	13598-13602	each	_
98-3	13603-13609	random	_
98-4	13610-13621	permutation	_
98-5	13622-13623	,	_
98-6	13624-13627	the	_
98-7	13628-13635	maximum	_
98-8	13636-13645	component	_
98-9	13646-13650	size	_
98-10	13651-13654	was	_
98-11	13655-13665	calculated	_
98-12	13666-13669	and	_
98-13	13670-13676	stored	_
98-14	13677-13679	in	_
98-15	13680-13681	a	_
98-16	13682-13686	null	_
98-17	13687-13698	intra-modal	_
98-18	13699-13711	distribution	_
98-19	13712-13713	.	_

Text=After 10 million permutations, the size of the actual intra-modal components was compared to the null size distribution extracted from the permuted data sets.
99-1	13714-13719	After	_
99-2	13720-13722	10	_
99-3	13723-13730	million	_
99-4	13731-13743	permutations	_
99-5	13744-13745	,	_
99-6	13746-13749	the	_
99-7	13750-13754	size	_
99-8	13755-13757	of	_
99-9	13758-13761	the	_
99-10	13762-13768	actual	_
99-11	13769-13780	intra-modal	_
99-12	13781-13791	components	_
99-13	13792-13795	was	_
99-14	13796-13804	compared	_
99-15	13805-13807	to	_
99-16	13808-13811	the	_
99-17	13812-13816	null	_
99-18	13817-13821	size	_
99-19	13822-13834	distribution	_
99-20	13835-13844	extracted	_
99-21	13845-13849	from	_
99-22	13850-13853	the	_
99-23	13854-13862	permuted	_
99-24	13863-13867	data	_
99-25	13868-13872	sets	_
99-26	13873-13874	.	_

Text=The p-value for significance in comparison to the null hypothesis was calculated by dividing the total number null model components larger than the actual component by the total number of permutations performed.
100-1	13875-13878	The	_
100-2	13879-13886	p-value	_
100-3	13887-13890	for	_
100-4	13891-13903	significance	_
100-5	13904-13906	in	_
100-6	13907-13917	comparison	_
100-7	13918-13920	to	_
100-8	13921-13924	the	_
100-9	13925-13929	null	_
100-10	13930-13940	hypothesis	_
100-11	13941-13944	was	_
100-12	13945-13955	calculated	_
100-13	13956-13958	by	_
100-14	13959-13967	dividing	_
100-15	13968-13971	the	_
100-16	13972-13977	total	_
100-17	13978-13984	number	_
100-18	13985-13989	null	_
100-19	13990-13995	model	_
100-20	13996-14006	components	_
100-21	14007-14013	larger	_
100-22	14014-14018	than	_
100-23	14019-14022	the	_
100-24	14023-14029	actual	_
100-25	14030-14039	component	_
100-26	14040-14042	by	_
100-27	14043-14046	the	_
100-28	14047-14052	total	_
100-29	14053-14059	number	_
100-30	14060-14062	of	_
100-31	14063-14075	permutations	_
100-32	14076-14085	performed	_
100-33	14086-14087	.	_

Text=Intermodal overlap (NBSm) After determining the intra-modal component for each modality, we investigated the anatomical locations of regions in each component separately and defined an “ intermodal overlap ” set to be the subset of nodes present in both intra-modal components.
101-1	14088-14098	Intermodal	_
101-2	14099-14106	overlap	_
101-3	14107-14108	(	_
101-4	14109-14113	NBSm	_
101-5	14114-14115	)	_
101-6	14116-14121	After	_
101-7	14122-14133	determining	_
101-8	14134-14137	the	_
101-9	14138-14149	intra-modal	_
101-10	14150-14159	component	_
101-11	14160-14163	for	_
101-12	14164-14168	each	_
101-13	14169-14177	modality	_
101-14	14178-14179	,	_
101-15	14180-14182	we	_
101-16	14183-14195	investigated	_
101-17	14196-14199	the	_
101-18	14200-14210	anatomical	_
101-19	14211-14220	locations	_
101-20	14221-14223	of	_
101-21	14224-14231	regions	_
101-22	14232-14234	in	_
101-23	14235-14239	each	_
101-24	14240-14249	component	_
101-25	14250-14260	separately	_
101-26	14261-14264	and	_
101-27	14265-14272	defined	_
101-28	14273-14275	an	_
101-29	14276-14277	“	_
101-30	14278-14288	intermodal	_
101-31	14289-14296	overlap	_
101-32	14297-14298	”	_
101-33	14299-14302	set	_
101-34	14303-14305	to	_
101-35	14306-14308	be	_
101-36	14309-14312	the	_
101-37	14313-14319	subset	_
101-38	14320-14322	of	_
101-39	14323-14328	nodes	_
101-40	14329-14336	present	_
101-41	14337-14339	in	_
101-42	14340-14344	both	_
101-43	14345-14356	intra-modal	_
101-44	14357-14367	components	_
101-45	14368-14369	.	_

Text=NBSm significance testing The significance of the intermodal set was determined using a set membership procedure.
102-1	14370-14374	NBSm	_
102-2	14375-14387	significance	_
102-3	14388-14395	testing	_
102-4	14396-14399	The	_
102-5	14400-14412	significance	_
102-6	14413-14415	of	_
102-7	14416-14419	the	_
102-8	14420-14430	intermodal	_
102-9	14431-14434	set	_
102-10	14435-14438	was	_
102-11	14439-14449	determined	_
102-12	14450-14455	using	_
102-13	14456-14457	a	_
102-14	14458-14461	set	_
102-15	14462-14472	membership	_
102-16	14473-14482	procedure	_
102-17	14483-14484	.	_

Text=With each permutation, the number of overlapping ROIs (i.e., those nodes present in both intra-modal components) was determined.
103-1	14485-14489	With	_
103-2	14490-14494	each	_
103-3	14495-14506	permutation	_
103-4	14507-14508	,	_
103-5	14509-14512	the	_
103-6	14513-14519	number	_
103-7	14520-14522	of	_
103-8	14523-14534	overlapping	_
103-9	14535-14539	ROIs	_
103-10	14540-14541	(	_
103-11	14542-14546	i.e.	_
103-12	14547-14548	,	_
103-13	14549-14554	those	_
103-14	14555-14560	nodes	_
103-15	14561-14568	present	_
103-16	14569-14571	in	_
103-17	14572-14576	both	_
103-18	14577-14588	intra-modal	_
103-19	14589-14599	components	_
103-20	14600-14601	)	_
103-21	14602-14605	was	_
103-22	14606-14616	determined	_
103-23	14617-14618	.	_

Text=The size of the intermodal overlap set and identity of the ROIs in this group were recorded.
104-1	14619-14622	The	_
104-2	14623-14627	size	_
104-3	14628-14630	of	_
104-4	14631-14634	the	_
104-5	14635-14645	intermodal	_
104-6	14646-14653	overlap	_
104-7	14654-14657	set	_
104-8	14658-14661	and	_
104-9	14662-14670	identity	_
104-10	14671-14673	of	_
104-11	14674-14677	the	_
104-12	14678-14682	ROIs	_
104-13	14683-14685	in	_
104-14	14686-14690	this	_
104-15	14691-14696	group	_
104-16	14697-14701	were	_
104-17	14702-14710	recorded	_
104-18	14711-14712	.	_

Text=A p-value for the significance of the size of the intermodal overlap set was generated by counting the number of permuted data sets in which the size of the intermodal overlap set was larger than the actual size and dividing this number by the number of permutations.
105-1	14713-14714	A	_
105-2	14715-14722	p-value	_
105-3	14723-14726	for	_
105-4	14727-14730	the	_
105-5	14731-14743	significance	_
105-6	14744-14746	of	_
105-7	14747-14750	the	_
105-8	14751-14755	size	_
105-9	14756-14758	of	_
105-10	14759-14762	the	_
105-11	14763-14773	intermodal	_
105-12	14774-14781	overlap	_
105-13	14782-14785	set	_
105-14	14786-14789	was	_
105-15	14790-14799	generated	_
105-16	14800-14802	by	_
105-17	14803-14811	counting	_
105-18	14812-14815	the	_
105-19	14816-14822	number	_
105-20	14823-14825	of	_
105-21	14826-14834	permuted	_
105-22	14835-14839	data	_
105-23	14840-14844	sets	_
105-24	14845-14847	in	_
105-25	14848-14853	which	_
105-26	14854-14857	the	_
105-27	14858-14862	size	_
105-28	14863-14865	of	_
105-29	14866-14869	the	_
105-30	14870-14880	intermodal	_
105-31	14881-14888	overlap	_
105-32	14889-14892	set	_
105-33	14893-14896	was	_
105-34	14897-14903	larger	_
105-35	14904-14908	than	_
105-36	14909-14912	the	_
105-37	14913-14919	actual	_
105-38	14920-14924	size	_
105-39	14925-14928	and	_
105-40	14929-14937	dividing	_
105-41	14938-14942	this	_
105-42	14943-14949	number	_
105-43	14950-14952	by	_
105-44	14953-14956	the	_
105-45	14957-14963	number	_
105-46	14964-14966	of	_
105-47	14967-14979	permutations	_
105-48	14980-14981	.	_

Text=A p-value for the significance of the presence of each ROI in the intermodal overlap set was determined by counting the number of permutations in which the ROI was identified as a member of the intermodal overlap set and dividing this number by the number of permutations.
106-1	14982-14983	A	_
106-2	14984-14991	p-value	_
106-3	14992-14995	for	_
106-4	14996-14999	the	_
106-5	15000-15012	significance	_
106-6	15013-15015	of	_
106-7	15016-15019	the	_
106-8	15020-15028	presence	_
106-9	15029-15031	of	_
106-10	15032-15036	each	_
106-11	15037-15040	ROI	_
106-12	15041-15043	in	_
106-13	15044-15047	the	_
106-14	15048-15058	intermodal	_
106-15	15059-15066	overlap	_
106-16	15067-15070	set	_
106-17	15071-15074	was	_
106-18	15075-15085	determined	_
106-19	15086-15088	by	_
106-20	15089-15097	counting	_
106-21	15098-15101	the	_
106-22	15102-15108	number	_
106-23	15109-15111	of	_
106-24	15112-15124	permutations	_
106-25	15125-15127	in	_
106-26	15128-15133	which	_
106-27	15134-15137	the	_
106-28	15138-15141	ROI	_
106-29	15142-15145	was	_
106-30	15146-15156	identified	_
106-31	15157-15159	as	_
106-32	15160-15161	a	_
106-33	15162-15168	member	_
106-34	15169-15171	of	_
106-35	15172-15175	the	_
106-36	15176-15186	intermodal	_
106-37	15187-15194	overlap	_
106-38	15195-15198	set	_
106-39	15199-15202	and	_
106-40	15203-15211	dividing	_
106-41	15212-15216	this	_
106-42	15217-15223	number	_
106-43	15224-15226	by	_
106-44	15227-15230	the	_
106-45	15231-15237	number	_
106-46	15238-15240	of	_
106-47	15241-15253	permutations	_
106-48	15254-15255	.	_

